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Glycans are expressed on surface of mammalian cells and tissues, and play 
important roles in diverse biological functions including cell-cell interaction, signal 
transduction, metastasis, etc. In xenotransplantation, a galactose-alpha-1,3-
galactose epitope, namely α-Gal, is the major carbohydrate xenoantigen that 
triggers hyperacute rejection (HAR) by the interaction of natural antibodies. 
Nevertheless, despite of production of α1,3-galactosyltransferase gene-knock out 
(GalT-KO) pigs as donors, there are still other antigens (e.g., non-Gal antigens) 
such as Hanganutziu-Deicher (H-D) antigen that induce acute vascular rejection 
(AVR) or delayed xenograft rejection (DXR) and subsequence xenograft failure. 
Mass spectrometry (MS) is a powerful tool for identification and structural 
elucidation of diverse and complex oligosaccharides. In addition, MS-based 
quantitative technologies for the oligosaccharide analysis have been developed in 
recent years. More recently, the improvement of mass spectrometry-based 
glycomics techniques (i.e. highly sensitive, quantitative and high-throughput 
analytical tools) has enabled us to obtain a large dataset of glycans.  
Cell-based glycomic analysis of WT and GalT-KO pig fibroblasts was 
performed by using matrix-assisted laser desorption/ionization time-of-flight 
(MALDI-TOF) MS and MALDI- quadrupole ion trap (QIT)-TOF MS/MS. Total 47 
N-glycans from WT and GalT-KO pig fibroblasts were identified and quantified. 
These results revealed that the level of overall sialylated glycans was higher in 
GalT-KO pig fibroblasts than WT, and relative quantity of N-glycolylneuraminic 
acid (NeuGc) antigen, which has been considered as one of non-Gal antigens, 
 ii
slightly increased in GalT-KO. The result proposed that the targeted knockout of 
α1,3-galactosyltransferase gene not only result in the removal of Galα1,3Gal 
residue but also influence sialylated glycan expression including NeuGc antigen. 
In the case of the pig tissue, the integrated MS-based glycomic analysis of 
GalT-KO pig kidney was carried out by MALDI-TOF MS, MALDI-QIT-TOF 
MS/MS, and electrospray ionization (ESI)-MS and MS/MS. The N-glycome 
derived from GalT-KO pig kidney was identified and quantified, and the result 
allowed an in-depth comparison of the total N-glycomic profiles between wild-type 
(WT) and GalT-KO. MS analysis revealed that the relative abundance of sialic 
acid-containing glycans increased in GalT-KO. The current analysis also enabled a 
priori identification of N-glycolylneuraminic acid (NeuGc) regarded as one of non-
Gal antigens in both WT and GalT-KO, and showed that the NeuGc level was 
higher in GalT-KO pig relative to WT.  
In addition, based on these glycome profiles of pig cells and tissues, a pig 
glycome database was developed here. The database contains cell- or tissue-
specific pig glycomes analyzed with mass spectrometry-based techniques, 
including the comprehensive pig glycan information on chemical structures, mass 
values, types and relative quantities. It was designed as a user-friendly web-based 
interface that allows users to query the database according to pig tissue/cell types 
or glycan masses. This database provides qualitative and quantitative information 
on glycomes characterized from various pig cells/organs in xenotransplantation. 
Finally, the study on pig glycome-human immune cell interactions was 
performed by fluorescence-activated cell sorting (FACS) and LC-MS/MS analysis. 
The in-vitro experiment of human immune cell activation against pig glycans, and 
 iii
the screening and identification of their surface proteins using glycan-immobilized 
beads were carried out. The results showed no difference associated with human 
immune cells between WT and GalT-KO pig. However, the more complete 
characterization of the interaction between pig glycans and human immune cells 
remained to be improved for the xenotransplantation research. 
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1.1 Overview of glycosylation in mammalian cells 
 
1.1.1 Glycan structure 
Glycan are abundantly expressed on the surface of mammalian cells, and 
constitute a large complex and diverse repertoire of structures collectively known 
as the ‘glycome’ (Figure 1.1). These glycans are classified into three major classes, 
which are N-linked glycan, O-linked glycan, and glycosphingolipid-derived glycan. 
The N-linked glycan (abbreviated to N-glycans) is covalently attached to the amine 
group in the asparagine (Asn) residue side chain. The N-glycosylation site on 
polypeptides or proteins is determined to the sequon Asn-Xaa-Ser/Thr, where Xaa 
is any amino acid residue except proline and aspartic acid [1, 2]. N-linked glycans 
are synthesized and processed as follows. The lipid-linked oligosaccharide 
precursor is synthesized in the endoplasmic reticulum (ER), and the precursor 
oligosaccharide (Glc3Man9GlcNAc2) is transferred from the lipid donor to the 
amine group in the protein Asn residue side chain. The core structure of N-linked 
glycan is composed of Man3GlcNAc2. Subsequently, N-linked glycans are 
processed by diverse enzymes (e.g. glycosylhydrolases and glycosyltransferases) in 
the ER and Golgi apparatus. The assembled N-linked glycan structures are 
classified into three different types: high-mannose type, complex type, and hybrid 
type N-linked glycan.  
O-linked glycan is most commonly attached to the hydroxyl group of the 
serine (Ser) or threonine (Thr) residues on proteins. The mucin-type O-glycan, 
which is the extended structure from a core N-acetylgalactosamine (GalNAc) α-




Figure 1.1 Three major glycan classes presented on the surface of mammalian 












glycosylation, there is no consensus sequence at O-glycosylation site on proteins. 
Protein O-glycosylation takes place in the secretory pathway after N-glycosylation. 
O-linked glycans are synthesized in a stepwise process, which is initiated by the 
transfer of N-acetylgalactosamine (GalNAc) to a peptide substrate by specific 
polypeptide GalNAc transferases (ppGalNAcTs). There are several different core 
structures of O-linked glycans based on differential monosaccharide linkage 
reactions (Figure 1.2). Core 1 subtype structure is Galβ1,3GalNAc formed by the 
transfer of Gal in a β1,3-linkage to the GalNAc. Core 2 subtype structure is 
GlcNAcβ1,6(Galβ1,3)GalNAc extended from the Core 1 structure by the addition 
of GlcNAc in β1,6-linkage. Core 3 subtype structure is GlcNAcβ1,3GalNAc 
formed by the addition of GlcNAc in β1,6-linkage to the GalNAc. Core 4 subtype 
structure is GlcNAcβ1,6(GlcNAcβ1,3)GalNAc extended from the Core 3 structure 
by the transfer of GlcNAc in β1,6-linkage. Most O-linked glycans contain a 
Galβ1,3GalNAc (Core 1) subtype structure. 
Glycolipids are synthesized in a stepwise process, similar to the O-linked 
glycan synthesis. The glycolipid synthesis is initiated by addition of a 
monosaccharide residue (glucose or galactose) to the sphingosineceramide though 
a glycolipid-specific glycosyltransferase. The core globoside, ganglioside, and 
lactoside structures are subsequently synthesized from glucosphingolipids. In 
contrast, galactosphingolipids form sulfate glycolipids which are attached to one or 
two additional monosaccharide residues. 
 
1.1.2 Biological functions of glycosylation on cell surface 
Protein glycosylation is one of largest and most important post-translational  
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Figure 1.2 Mammalian glycan structures. (a) N-linked glycans attached to Asn of polypeptides or proteins (sequon 
Asn-Xaa-Ser/Thr), (b) O-linked glycans covalently attached to Ser/Thr of polypeptides or proteins. There are eight 
different core structures of O-glycans [4]
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modifications. The glycosylation plays significant roles in numerous biological 
processes such as cell development, cell-cell interactions and signaling [5-7], 
immune response [8, 9], and tumor growth and metastasis [10, 11] etc,. Within the 
immune system, the interaction between carbohydrate and proteins serve various 
functions in cell activation, differentiation, and homing (Figure 1.3). There are 
diverse glycan-binding proteins (GBPs) that recognize specific glycan structures 
expressed on the surface of mammalian cells (Figure 1.4). Many of GBPs are 
members of C-type lectin receptor (CLR) family, which are calcium-dependent 
carbohydrate-binding proteins. These CLRs such as dendritic cell-Specific 
intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), macrophage 
galactose-specific lectin (MGL), langerin, and mannose receptor recognize fucose-
linked glycans (Lewis antigens), GalNAc or GlcNAc epitope, and high-mannose 
type glycans [12-15]. C-type lectins have functions as pathogen recognition, cell 
adhesion and signaling receptors [16]. Galectins are a family of proteins that have a 
specificity for N-acetyllactosamine (Galβ1,4GlcNAc) epitope of carbohydrates by 
a conserved carbohydrate-recognition domain (CRD) [17, 18] Activated B cells 
and T cells express these soluble galectins, which participate in the modulation of 
activated macrophages and regulatory T cells, and thereby produce cytokines [19, 
20]. Siglecs are a member of sialic acid-binding immunoglobulin-like lectins, 
which control cell functions in immune systems. These siglecs are classified into 
two types based on sequence similarity and evolutionary conservation, which are 
CD33-related siglecs and siglecs common to mammals [e.g., Sialoadhesin, CD22, 
myelin-associated glycoprotein (MAG), Siglec-15] [21]. The siglecs are 
abundantly presented on the surface of various immune cells such as monocytes,  
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Figure 1.3 The interaction between specific glycans and protein receptors 














Figure 1.4 Oligosaccharide ligands against the three major lectins (C-type lectins, 
galectins, and siglecs) in the immune system [22]. The oligosaccharide structures 








dendritic cells, and neutrophils, etc. It has been commonly demonstrated that these 
glycan-binding proteins have a specificity for sialic acids but can distinguish 
among sialic acid linkages (α2,3-, α2,6-, and α2,8-linkage) by which the sialic acid 
residues are linked to the oligosaccharide structure. The molecular interactions 
between the sialic acid and siglec lead to communication of immune cells. In 
addition, the siglecs involve in pathogen recognition because sialic acid-terminated 
sugars are also reported on pathogenic microorganisms including Helicobacter 


















1.2 Glycobiology in xenotransplantation 
 
1.2.1 Xenotransplantation in GalT-KO era 
Due to shortage of human donor organs, it has increased the interest in 
xenotransplantation. The pig, of non-human primates, has been a preferred source 
as donor because of anatomic and physiologic similarity and ethical acceptance. 
However, there is strong immune response in pig-to-human xenotransplantation 
(Figure 1.5). A galactose-alpha-1,3-galactose epitope (α-Gal) is the major 
carbohydrate xenoantigen expressed on surface of non-human cells and tissues, and 
triggers HAR to xenograft through the interaction with natural anti-α-Gal 
antibodies. To solve this problem, GalT-KO pigs, which do not express the α-Gal 
antigen, have been produced [23-25]. This approach, deletion of α-Gal expression 
in donors, is one of efficient approaches as a solution to antibody-mediated 
xenotransplantation rejection (Table 1.1). 
However, even after the production of GalT-KO pigs as donors, there still 
remains non-Gal antigens present on pig cell surfaces. These antigens react with 
anti-non-Gal antibodies in human sera, and therefore induce AVR or DXR in 
xenotransplantation [26, 27]. The NeuGc-terminated carbohydrate antigen (e.g. H-
D antigen), of non-Gal antigens, has been considered as an important xenoantigen 
in GalT-KO pig era. Anti-HD antibodies account for a large proportion of total anti-
non-Gal antibodies in human sera [28]. Moreover, the targeted disruption of α1,3-
galactosyltransferase gene leads to the perturbation of other genes and 
consequently results in unknown phenotypic effects such as increase or decrease of 




Figure 1.5 Humoral rejection. Immune rejection responses such as HAR and 
AHXR occured via the interaction between xenoantigens and xenoreactive natural 












Table 1.1 Strategies to overcome antibody-mediated xenotransplantation rejection [31] 
 
Approach Strategy  
Efficacy  
(short term/long term) 
Inhibition of complement 
activation 
Recipient: cobra-venom factor, soluble complement 
receptor 
High/low 
Donor: expression of human complement regulatory 
protein (CRP) transgenes 
High/low 
Depletion of α-Gal-
specific antibody in 
recipients 
Ex vivo haemoperfusion and injection of soluble 
xenoantigen conjugates 
High/low 
Accommodation* Transient depletion of xenoreactive natural antibody 
or complement 
High/unknown 
Antithrombosis and/or Recipient: anticoagulants or antiplatelet agents Low/low 
 １３
anticoagulation Donor: expression of human CD39 and natural 
anticoagulants 
Unknown/ unknown 
Reduction or deletion of 
α-Gal expression in 
donors 
Transgenic expression of human α1,2-
fucosyltransferase 
Low/low 
α1,3-galactosyltransferase deficiency High/high 
B-cell tolerance* Induction of mixed chimerism High/high 
*Based on studies in rodent xenotransplantation models.
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1.2.2 Immune system in xenotransplantation 
In addition to the function of natural antibodies, it has been recently 
demonstrated that several other elements in innate immune system play an 
important role in AVR/DXR [32] as shown in Figure 1.6. Human natural killer 
(NK) cells have a direct interaction with non-human cells (e.g. pig cells), and hence 
mediate xenograft rejection. The NK cells also indirectly participate in xenograft 
rejection. Li et al. have demonstrated that the NK cells contribute to the production 
of T-cell independent xenoantibody [33], and Xu et al. have demonstrated that the 
activated NK cells increase T cell xenoreactivity [34]. A recent study on human 
macrophage provided evidence that the macrophage recognizes xenogeneic cells 
via the interaction between human signal-regulatory protein-α (SIRPα) and CD47 
(integrin-associated protein), and lead to inhibition of phagocytosis. Monocytes are 
also one of the most significant inflammatory cells and involve in DXR. It has 
recently been reported that the α-Gal antigen activates human monocytes via the 
interaction with human monocyte receptor Galectin-3 [35], suggesting that human 
macrophage also recognizes the α-Gal antigen because Galectin-3 is expressed on 
the human macrophage as well as the monocyte. Some studies indicated that 
human neutrophils can recognize porcine endothelial cells but not allogeneic 
endothelial cells, and subsequently that express high levels of adhesion molecules.  
The porcine endothelial cells were previously reported to produce a secreted 
molecule promoting the adhesion of human neutrophils [36]. This interaction 
results in NK cell lysis [37, 38], and occurs regardless of α-Gal epitope [39]. 
 




Figure 1.6 Cellular rejection. NK cells and macrophages play a central role in 











1.2.3.1 α-Gal antigen in pig tissues 
There are several carbohydrate antigens that may be relevant in pig-human 
xenotransplantation (Table 1.2). As illustrated above, α-Gal antigen 
(Galα1,3Galβ1,4GlcNAc residue) is regarded as the most vital xenoantigenic 
carbohydrate expressed on surface of non-human primates, which have the enzyme 
α1,3-galactosyltransferase (GGTA1) that synthesize the α-Gal antigen. This 
carbohydrate antigen on xenograft endothelium binds to natural anti-α-Gal 
antibodies in the sera, and subsequently the interaction activates complement 
system and coagulation cascades followed by triggering HAR within minutes to 
hours [40-42].  
Although GalT-KO non-human primates were produced for preventing the 
HAR on xenograft, there has been a controversy over the elimination of α-Gal 
antigens. A previous study reported that GalT-KO pigs expressed low levels of α-
Gal antigen and other α1,3-galactosyltransferase, GGTA2 was reported to 
synthesize isoglobotriaosylceramide (iGb3; Galα1,3Galβ1,4Glcβ1-ceramide) as an 
alternative α-Gal antigen candidate in GalT-KO non-human primates [43, 44] 
suggesting that there are two different glycan processing pathway for the synthesis 
of Galα1,3Gal disaccharide [45]. Therefore, it is essential to confirm the complete 
absence of the α-Gal antigen in GalT-KO animals for pre-clinical trial in 
xenotransplantation. 
 
1.2.3.2 non-Gal antigens 
1.2.3.2.1 N-glycolylneuraminic acid 
The sialic acid is one the most common epitopes of oligosaccharide attached 
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Table 1.2 Xeno-antigenic carbohydrate structures (α-Gal and non-Gal antigens) 
















to proteins and lipids. These sialic acids are divided into two major classes, which 
are N-acetylneuraminic acid (NeuAc) and N-glycolylneuraminic acid (NeuGc). In 
stark contrast to the NeuAc, which is ubiquitously expressed, the NeuGc antigen is 
presented in mammalian species such as pigs and monkeys, but absent in human 
and birds [46-48]. O-acetylated sialic acids were also found in non-human primates 
such as cow and horse [49], which can be positioned at C4,C7, C8 or/and C9 of the 
sialic acid structure. 
The Hanganutziu-Deicher antigens (H-D antigens), which are glycolids 
containing the NeuGc xenoantigen, has been regarded as one of the non-Gal 
antigens in pig organs [50]. NeuGc is mainly synthesized via hydroxylation of 
NeuAc by CMP-N-actetylneuraminic acid hydroxylase (CMAH) with cytochrome 
b5 and NADH cofactors [51, 52] (Figure 1.7). Bouhours et al. first identified H-D 
antigens in pig endothelial cells, and recognized by anti-H-D antibodies in the 
human serum [53]. Recently, N- and O-linked glycans as well as glycolipids have 
been reported to contain NeuGc residues on the surface of pig cells and tissues [54-
58]. In addition, some studies showed the various expression levels of NeuGc 
antigens according to the pig organ [29, 59].  
In spite of the importance of NeuGc antigenecity, the quantitative 
measurement of the NeuGc antigens is a difficult task because there is no available 
lectin which specifically binds to the NeuGc epitope. A recent study reported that 
quantification of NeuGc was performed by 1,2-diamino-4,5-
methylenedioxybenzene (DMB) derivatization of sialic acids [29], but not 





Figure 1.7 Biosynthesis of NeuGc. Hydroxylation of NeuAc by CMP-N-


















1.2.3.2.2 Other non-Gal antigens 
Some other carbohydrate constituents have been suggested as potential 
xenoantigens, which may play a role in human immune system on 
xenotransplantation [60]. Swanson et al. identified Tn (GalNAcα-R) and sialyl-Tn 
(NeuAcα2-6GalNAcα-R) antigens in porcine red blood cells [61], and Kirkeby et 
al. characterized Tn antigen in pig kidney [62]. A recent study also detected the Tn 
antigen expressed on GalT-KO pig endothelial cells as well as fibroblasts [63]. 
These antigens have been extensively reported to involve in humoral and cellular 
immune response in human cancer [64, 65]. The preformed natural antibodies 
specific for these antigens have been found in some humans [65]. 
Forssman antigen (GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ1-R) is an 
non-Gal antigen candidates on pig to human xenograft, which is presented on the 
cell surface of Forsmann positive species such as pigs, sheep, and hamsters [66]. 
Although this antigen was expressed on human cancer [67, 68], and anti-Forsmann 
antibodies were found in normal human sera [69], human has been considered as 










1.3 Analytical methodologies in glycobiology 
 
1.3.1 Qualitative glycomic analysis 
As described above, the glycosylation plays roles in many cellular processes 
including cell adhesion, immune response, and signal transduction, etc. Therefore, 
the analysis of glycan structures is important issue for understanding molecular 
mechanisms involved in these events. Analytical technology for oligosaccharide 
sequencing has been developed based on exoglycosidase sequencing and tandem 
mass spectrometric analysis 
 
1.3.1.1 Exoglycosidase sequencing 
Enzymatic glycan analysis using exoglycosidases has been a powerful 
analytical approach for determination of glycan sequence because the enzyme(s) 
remove specific terminal monosaccharides (Figure 1.8) [70]. Furthermore, the 
simultaneous digestion of oligosaccharide can be rapidly carried out using various 
enzyme arrays [71], and subsequently the oligosaccharide fragment products from 
the sequential exoglycosidases are analyzed by HPLC or MS instruments [55, 56, 
72]. To detect oligosaccharides in the HPLC instrument, the reducing end of the 
oligosaccharides is chemically labeled with fluorescent molecules such as 2-
aminobezamide (2-AB) [73]. Structural assignment can be determined by elution 
positions of the glycan because incremental values are calculated for individual 
carbohydrate residue from oligosaccharide core structures [72] (Figure 1.9). More 
recently, a HPLC technology coupled with glycan database which contains glucose 




Figure 1.8 Specificities of exoglycosidase digestion for identify glycan structures. 
ABS: Arthrobacter ureafaciens sialidase (EC 3.2.1.18); NAN1: Streptococcus 
pneumoniae sialidase (EC 3.2.1.18); BTG: bovine testes β-galactosidase (EC 
3.2.1.23); SPG: S. pneumoniae β-galactosidase (EC 3.2.1.23); AMF: almond meal 
α-fucosidase (EC 3.2.1.51); BKF: bovine kidney alpha-fucosidase (EC 3.2.1.51); 












Figure 1.9 HPLC profiles before/after sequential exoglycosidase digestion of N-












identification of N-linked glycans as well as quantitation [74]. However, such an 
HPLC-based analysis has a limitation for the characterization of unknown or 
unique glycan structures. 
 
1.3.1.1 Tandem mass spectrometric analysis 
MS has lead to recent advances in the field of structural glycomics because of 
its high-performance in mass range, resolution, and sensitivity. Moreover, MS/MS 
(or MSn) analysis allowed simultaneous sequencing of oligosaccharides through 
ion fragmentation processes such as collision induced dissociation (CID) in ESI-
MS/MS and MALDI-in source decay (ISD) or post source decay (PSD). Most 
tandem mass spectrometric analyses have been used by CID, which technique 
makes precursor ions into a collision cell fragmented by collision with a neutral gas 
such as Helium (He) and Argon (Ar). The nomenclature for carbohydrate fragment 
ions [75] is shown in Figure 1.10. The fragment ions containing the non-reducing 
end in oligosaccharides are labeled as A-, B-, C-ions while those containing 
reducing terminus are indicated as X-, Y-, Z-ions. In contrast to MALDI-TOF 
MS/MS, which produces more complicated cleavage ions, ESI-MS/MS or 
MALDI-QIT-TOF MS/MS equipped with ion trap instrumentation yields simple 
product ions. The mass fragmentation pattern represents predominant B- and Y-
ions, which are generated from glycosidic bond cleavage, while cross ring 
fragment ions (A- and X-ions) are weak or absent. Unlike HPLC analysis, this 
tandem mass spectrometric analysis allowed the elucidation of unknown or unique 
oligosaccharide sequences. The alternative fragmentation methods of electron 




Figure 1.10 Nomenclature for carbohydrate fragmented ions (A-, B-, C- and X-, Y-, 
















recently demonstrated for glycopeptide and other PTM analysis [76-78]. However, 
these MS/MS techniques generated dissociation resulting in the production of 
relatively abundant cross-ring cleavage ions that are highly informative for detailed 
structural identification of sialylated and neutral glycans [79]. A previous study 
also reported application to glycan analysis using alkali, alkaline earth, and 




















1.3.2 Quantitative glycomic analysis 
 
1.3.2.1 Lectin-based assay and HPLC analysis 
A number of studies for oligosaccharide identification of prokaryotic and 
eukaryotic cells/tissues have used a lectin-based approach [81-83] (Figure 1.11). 
However, such an approach has a limitation for qualitative and quantitative 
analysis of glycomes. For example, there are a limited number of lectins which are 
available, and these lectin-based methods enable the classification of structural 
oligosaccharide motifs but not the elucidation of the entire chemical structures of 
oligosaccharides. Furthermore, the quantitative evaluation of glycomes by these 
methods might be less reliable compared with other analytical methods. 
High-performance liquid chromatography (HPLC) analysis combined with 
fluorescent oligosaccharide labeling is the conventional method for identification 
and quantification of glycans. Because the carbohydrate has no UV absorbing or 
fluorophore group, the fluorophore such as 2-aminobenzoic acid (2-AA) and 2-AB 
[73, 84] was introduced on the reducing end of oligosaccharides as described above, 
and resulted in sensitive detection of oligosaccharides at the femtomole level [85, 
86]. Hydrophilic interaction chromatography (HILIC) provided improved 
resolution for complex glycan mixtures. Moreover, this analytical technique 
enabled the separation of oligosaccharide structural isomers which is challenging to 
other techniques. Nonetheless, these HPLC-based glycan analyses are difficult to 
identify large and diverse glyconjugates isolated from mammalian cells and tissues 
because a limited number of oligosaccharide standards are available. 





Figure 1.11 Scheme of lectin-based (a) single-color and (b) dual-color microarray 
for relative oligosaccharide quantification [87, 88] 
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However, in spite of wide application to structural analysis as described above, MS 
has a limitation for quantitation of oligosaccharides because the oligosaccharide 
mixture in biological samples (e.g. human serum) has various ionization 
efficiencies resulting from the complexity and diversity of glycan structure. MS has 
been also used in the identification of GalT-KO pig glycans in recent years. 
Diswall et al. and Puga Yung et al. recently reported on the glycolipids-derived 
glycans isolated from GalT-KO pig tissues and cells [89, 90]. However, there are 
no previous both structural and quantitative glycomic studies regarding GalT-KO 
pig glycomes using MS-based approach. 
 
1.3.2.2 MS-based glycomic analysis 
1.3.2.1 Girard reagent’s T derivatization 
The previous study presented relative and absolute quantitative analysis of 
neutral oligosaccharides by derivatization with carboxymethyl trimethylammonium 
hydrazide (also called Girard’s reagent T) [91] (Figure 1.12). A permanent cationic 
charge was introduced on the reducing end of oligosaccharides, and consequently 
MALDI-TOF MS spectra showed that [M+GT]+ was mainly produced from 
heterogeneous metal adduct ions such as [M+H]+, [M+Na]+, and [M+K]+. As a 
result, peak ion intensities in the MALDI-TOF MS spectra revealed a good 
linearity with the concentration (or amount) of glycan samples. However, this 
method is impossible to quantify sialic acid-containing glycans due to the negative 
charge state occurred in the sialic acid residue. 
 




Figure 1.12 Derivatization of the glycan reducing end with carboxymethyl 











Permethylation method has been commonly used in many glycomic studies [92]. 
The permethylation of oligosaccharides allows for significantly increasing MS 
detection sensitivity compared to other oligosaccharide derivatization methods, and 
simplifying interpretation of tandem mss spectra for structural identification of 
oligosaccharides. This derivatization is resulted from the chemical reaction of 
oligosaccharides with iodomethane in sodium hydroxide solution (NaOH). 
However, the problem of this conventional permethylation is believed to be 
dependent on oxidative degradation and peeling reactions under harsh basic 
conditions by NaOH solution. To overcome this shortcoming, Kang et al. pioneered 
solid-phase permethylation technique prior to MS analysis for micro-scale 
determination [93]. The MALDI-TOF MS analysis combined with the solid-phase 
permethylation approach permits comprehensive identification of both neutral and 
acidic glycans and therefore simultaneous quantitation of total glycans on 
biological samples because the solid-phase permethylation stabilized labile sialic 
acids by minimizing oxidative degradation and peeling reactions. Recently, 
permethylation coupled with commercially available stable isotope reagents has 
been used for comparative glycomic mapping [94]. (Figure 1.13) 
 
1.3.2.4 Acetohydrazide amidation for sialylated glycan analysis 
Although the introduction of a permanent charge on oligosaccharides result in 
provide reliable quantitation through MS instruments as mentioned above, this 
approach has a difficulty to apply for acidic oligosaccharide analysis. A previous 
study developed the neutralization of the sialic acid in oligosaccharides using 











glycans from the recombinant therapeutic glycoproteins [96]. However, incomplete 
modification of α2,3-linked sialylated glycans as well as the loss of sialic acids 
were occurred in the methyl-esterification reaction. Unlike methyl-esterification, 
amidation using acetohydrazide reagent under mild acidic condition has been 
reported to prevent the sialic acid of glycans from degradation and incomplete 
modification [97]. A recent study on quantitative glycomic analysis have reported 
on neutralization of sialic acids of oligosaccharides in combination with labeling of 
permanent charges on the reducing end [98] (Figure 1.14). This result showed that 
















Figure 1.14 An approach for MS-based quantitation of sialylated glycans. (a) acetohydrazide amidation for 
neutralization of the sialic acid, (b) a scheme of oligosaccharide preparation from glycoproteins using 
acetohydrazide amidation. 
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1.4 Database in glycobiology 
1.4.1 Importance of big data processing and current status in glycobiology 
Because there is a need for researchers to access what is already known in 
their field, databases are invaluable bioinformatics tools for scientific research. In 
genomics and proteomics field, database has become an indispensable tool for 
research, but the application of databases for glycomics is less frequent than 
genomics and proteomics. However, as it increases in the availability of glycan 
analytical technologies and quantity of data, it becomes more important to data 
collection for glycans, and thus actually requires glycome data repositories and 
their processing software tools. To this end, during the past decades, several 
databases have been developed to assist the assignment, annotation and 
interpretation of glycan and glycoconjugates datasets [74, 99-103] (Table 1.3). 
However, none of them systematically classify and update the pig glycans 
according to the specific pig tissues and cells. Qualitative and quantitative 
information on the glycan antigens, which play an important role in immune 








Table 1.3 Glycan data management: glycan database and its resources [4] 
 
Database  URL  
Integrated 
databases  
GlycomeDB  http://www.glycome-db.org  
EuroCarbDB  http://www.ebi.ac.uk/eurocarb  
 CFG  http://functionalglycomics.org  
 GlycoSuiteDB  http://glycosuitedb.expasy.org/glycosuite/glycodb 
 Glycosciences DE http://www.glycosciences.de/index.php 
















Glycobase (Lille) http://glycobase.univ-lille1.fr/base 
CCSD (CarbBank) http://boc.chem.uu.nl/sugabase/carbbank.html 
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2.1 Structural analysis and quantitation of pig cell and tissue glycomes using 
mass spectrometry 
 
2.1.1 Isolation of homozygous GalT KO pig fibroblast cells 
 
Fibroblasts were cultured from ear skin biopsies of the heterozygous GalT KO 
piglets as previously reported [104]. Selection of homozygous GalT KO cells 
derived from loss of heterozygosity was performed as described elsewhere [105]. 
Briefly, 5 x 105 heterozygous GalT KO cells were washed twice with Dulbecco’s 
phosphate buffered saline (DPBS), resuspended with 1 ml of DPBS containing 4 
μg biotin-conjugated IB4-lectin (EY Laboratories, San Mateo, CA, USA) in a 1.5-
ml tube, and incubated for 1 hr on ice with tapping the tube to prevent precipitation 
of the cells. After washing cells twice with DPBS by centrifugation, 4 mg of 
Dynabeads M-280 Streptavidin (Invitrogen, Carlsbad, CA, USA) was added to the 
pellet and the resulting mixture was again incubated same as the IB4-lectin 
treatment. Then, the tube was placed on a magnet for 2-3 min, and the supernatant 
was transferred to a new tube on a magnet. This procedure was repeated three times. 
The final supernatant was cultured in Dulbecco’s modified Eagle medium 
(DMEM) containing 10% (v/v) fetal bovine serum (FBS) in 60-mm culture dish for 
10-14 days until colonies reached approximately 2 mm in diameter. The culture 
dish containing fibroblast colonies was washed twice with DPBS and covered with 
dimethylpolysiloxane (DMPS). Colonies were dissociated by injecting 30 μl of 
0.25% trypsin-EDTA on top of each colony underneath DMPS using micropipette. 
After incubation for 5 min at 39°C, fibroblasts dissociated from each colony were 
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transferred onto 0.1% gelatin-coated 24-well culture dish for clonal culture. Clones 
of homozygous GalT KO were analyzed by PCR as previously reported (Ahn et al., 
2011). Briefly, genomic DNA was prepared from fibroblasts using DNeasy Tissue 
Kit (Qiagen, Valencia, CA) according to the manufacturer's protocol. Using 
Maxime PCR premix kit (Intron Biotechnology, Seongnam, Korea) in 20 μL 
reaction volume, amplification of the target gene was carried out using forward 5'-
AGAGGTCGTGACCATAACCAGAT-3' and reverse 5'-
AGCCCATGCTGAACATCAAGTC-3' primers. Conditions for PCR were as 
follows: 30 cycles of 15 s at 94°C, 30 s at 65°C, 10 min + 20 s increase/cycle at 
68°C; and one final cycle of 7 min at 68°C. Amplification products (9.2 kb GalT 
gene-targeted and/or 7.4-kb wild type allele,) were analyzed by 0.4% agarose gel 
electrophoresis. Fibroblasts confirmed to be GalT KO were used for subsequent 
experiments. 
 
2.1.2 Preparation of membrane fractions from pig fibroblasts 
 
Cell membrane fractionation procedure was performed following a previously 
described study [56], with minor modifications. Briefly, pig fibroblasts (wild-type 
and GalT-KO, respectively) consisting of 1 x 106 ~ 1 x 107 cells were washed with 
twice with 1 x phosphate buffered saline (PBS) by centrifugation at 90 x g for 5 
min. The washed cell pellets were homogenized by sonication followed by 
centrifugation at 3,500 rpm for 10 min to remove cell debris and nuclear fraction. 
The supernant was centrifuged at 100,000 x g for 1 h and then precipitates 
(membrane fraction) were washed with 1 x PBS three times to remove cytosol 
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fraction. The washed precipitates were dissolved in 50 mM sodium phosphate 
buffer (pH 7.5) for further enzyme reaction. 
 
2.1.3 Preparation of membrane fraction from GalT-KO pig kidney 
 
Centrifugation and incubation were carried out at 4 °C and all fractions were 
stored at -20 °C until further use. Membrane fractionation protocol was performed 
according to our previous studies [106, 107]. Briefly, the fresh GalT-KO pig kidney 
tissue was sliced and homogenized in 1 x Tris-buffered saline (TBS) (50 mM Tris, 
150 mM NaCl, pH 7.5) containing protease inhibitor cocktail tablets (Roche, 
Germany) using a motor-driven homogenizer. The tissue homogenate was 
centrifuged at 3,500 rpm for 10 min to remove cell debris and nuclear fractions. 
Membrane proteins were fractionated through centrifugation at 40,000 rpm for 2 h 
using an ultracentrifuge (Beckman Ti 70 rotor), and then the precipitates were 
washed with 1 x phosphate buffered saline (PBS) three times to remove residual 
cytosol fractions. The washed precipitates were resuspended in 50 mM sodium 
phosphate buffer (pH 7.5) for further N-deglycosylation enzyme reaction. 
Membrane protein concentration (6.6 mg/mL) was determined by the Bradford 
assay using a BSA standard. 
 
2.1.4 Glycan release form pig fibroblasts and kidney membrane fractions 
 
The membrane proteins were denatured at 95 °C for 3 min. After cooling to 
room temperature, the proteins were deglycosylated by treatment with peptide N-
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glycosidase F (PNGase F; Roche, Germany) (5 U) followed by incubation at 37 °C 
for 16 h. After N-deglycosylation, ethanol precipitation was performed by the 
addition of a 4-fold volume of cold ethanol and incubation for 2 h at -20 °C, and 
supernants containing N-linked glycans and precipitants (N-deglycosylated 
proteins) were separated by centrifugation at 13,500 rpm for 15 min at 4 °C. 
Collected supernants were carefully transferred to new tubes and dried with a 
centrifugal vacuum concentrator for further purification. 
 
2.1.5 Purification of released glycans 
 
For purification of N-linked glycans from salts and other contaminants, porous 
graphitic carbon (PGC) cartridge (HyperSep Hypercarb SPE, Thermo Scientific, 
Bellefonte, PA, USA) was used. The purification protocol was as follows: First, the 
cartridge was washed with 30% (v/v) acetic acid/water followed 50% (v/v) 
acetonitrile (ACN)/water containing 0.1% trifluoroacetic acid (TFA). Next, the 
cartridge was equilibrated with 5% (v/v) ACN/water containing 0.1% TFA and then 
the released N-linked glycans dissolved in water were loaded onto the cartridge. 
Subsequently, the cartridge was washed with water followed by 5% (v/v) 
ACN/water containing 0.1% TFA. The N-linked glycans were eluted with 50% 
(v/v) ACN/water containing 0.1% TFA, and then the collected eluent was dried 
completely with a centrifugal vacuum concentrator for further steps. 
 
2.1.6 Exoglycosidase digestion of purified glycans 
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The purified N-linked glycans were treated with exoglycosidases (Prozyme, 
Hayward, CA, USA) according to manufacturer’s protocol. The exoglycosidases 
used in this study are as follows: Arthrobacter ureafaciens sialidase (EC3.2.1.18, 
specificity for α(2-6/3/8)-linked nonreducing terminal N-acetylneuraminic acid 
(NeuAc) and N-glycolylneuraminic acids (NeuGc)), bovine testes β-galactosidase 
(EC3.2.1.23, specificity for nonreducing terminal galactose with β(1-3/4) linkages). 
β-N-acetylhexosaminidase cloned from S. pneumoniae, expressed in Escherichia 
coli (EC3.2.1.30, specificity for β(1-2/3/4/6)-linked N-acetyl-glucosamine), and 
green coffee bean α-galactosidase (EC 3.2.1.22, specificity for α(1-3/4/6)-linked 
galactose). Deglycosylated glycans were purified from exoglycosidase enzyme(s) 
using Amicon®Ultra Centrifugal Filters (Millipore, Billerica, MA, USA) for further 
MS analysis. 
 
2.1.7 Solid-phase permethylation of purified glycans 
 
The purified N-glycans were permethylated using the solid-phase 
permethylation method [93]. Briefly, micro spin column (Harvard Apparatus, 
Holliston, MA, USA) were first filled with sodium hydroxide (NaOH) beads. Next, 
the spin column was washed dimethyl sulfoxide (DMSO) and then the N-glycans, 
which are dissolved in 141.6 μL of DMSO, 52.8 μL of iodomethane (CH3I), and 
5.6 μL of water, was applied to the NaOH-packed spin column. Subsequently, the 
sample was passed for at least eight times through the spin column by 
centrifugation at 1,200 rpm for 15 sec. The spin column was washed with 100 μL 
of ACN followed by centrifugation at 10,000 rpm for 1 min for complete collection 
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prior to two-phase extraction. The collected N-glycans were extracted from the 
sample solution with 200 μL of chloroform and 200 μL of water and neutralized 
with water until pH 6-7. Chloroform layer containing permethylated N-glycans was 
then dried prior to for further MS analyses. 
 
2.1.8 Matrix-assisted laser desorption/ionization time-of-flight mass  
spectrometry (MALDI-TOF MS) analysis 
 
0.5 μL of the sample solutions were mixed with 0.5 μL of 2,5-
dihydroxybenzoic acid (DHB) solution (30 mg/mL in 30/70 (v/v) water/ACN). 1 
μL of the mixture was spotted on stainless steel MALDI plate and dried at R.T. MS 
analysis was performed using a MALDI-TOF (matrix-assisted laser 
desorption/ionization time-of-flight) MS instrument with an Autoflex system from 
Bruker Daltonics (Bruker, Breman, Germany) and controlled by FlexControl 3.0 
software (Bruker, Breman, Germany) according to manufacturer’s protocols. The 
analysis parameters were as follows: positive-ion and reflectron mode, detector 
gain = 5.4 and laser power = 70%. Peptide calibration standard II (Bruker, Breman, 
Germany) of Angiotensin II (m/z 1046.54), Angiotensin I (m/z 1296.68), Substance 
P (m/z 1347.74), Bombesin (m/z 1619.82), ACTH1-17 (m/z 2093.09), ACTH18-39 
(m/z 2465.20), Somatostatin (m/z 3147.47) was used for mass accuracy. 10,000 
different spots were scanned to acquire a mass spectra data. The intensity of each 
peak was obtained by integrating from first to third isotopic peaks intensity. Data 
acquisition and processing were performed with flexAnalysis 3.3 software (Bruker, 
Breman, Germany). The GlycoMod (http://web.expasy.org/glycomod) was used for 
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determination of glycan compositions from measured masses. 
 
2.1.9 Electrospray ionization mass spectrometry (ESI-MS) analysis 
 
Dissolved in 4 μL water and 1 μL samples cleaned with a Nafion membrane 
[108]. Samples were diluted with 4 μL 0.1 M ammonium phosphate (to ensure that 
all neutral glycans formed [M+(H2PO4)]
- ions) and 5 μL methanol and spun at 
10,000 rpm (9503 x g) in a bench centrifuge for 1 min. Samples were infused 
through Waters thin-wall nanospray capillaries into a Waters Synapt G2 travelling 
wave ion mobility mass spectrometer (Waters MS-technologies, Manchester UK) 
[109] fitted with an electrospray (ESI) ion source. The instrument was operated in 
negative ion mode. The ESI capillary voltage was 1.2 kV, the cone voltage was 20-
180 V and the ion source temperature and desolvation temperature were maintained 
at 80°C and 120°C respectively. The T-wave velocity and peak height voltages 
were 450 m/sec and 40 V respectively. Instrument calibration was performed with 
released N-glycans from bovine fetuin. The T-wave mobility cell (nitrogen) was 
operated at a pressure of 0.55 mbar. Fragmentation was performed after mobility 
separation in the transfer cell with argon as the collision gas. Data acquisition and 
processing were carried out using the Waters Driftscope (version 2.1) software and 
MassLynxTM (version 4.1). The scheme devised by Domon and Costello [110] was 
used to name the fragment ions and the structures were drawn with the scheme 
devised by Harvey et al. [111]. 
 
2.1.10 MALDI-quadrupole ion trap (QIT)-TOF MS/MS analysis 
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0.5 μL of The sample solutions were mixed with 0.5 μL of DHB solution (10 
mg/mL in 30/70 (v/v) water/ACN) and subsequently subjected to MALDI-TOF 
MS/MS analysis. MS/MS analysis was performed using an Axima Resonance 
MALDI-quadrupole ion trap-TOF instrument (Shimadzu, Manchester, UK). The 
analysis parameters were as follows: positive-ion and reflectron mode. The TOF 
detector was calibrated as described above. Fragment ions generated by collision-
induced dissociation (CID) of the precursor ions were analyzed after passing 
through the ion reflector. Data acquisition and processing were performed with 
Launchpad 2.9.3 software (Kratos Analytical Ltd, Manchester, UK). 
 
2.1.11 Statistical analysis 
 












2.2 Development of qualitative and quantitative pig glycome database 
 
2.2.1 Design and implementation 
 
XDB is based on open-source technology, developed in jruby 1.7.0 and 
trinidad1.4.4 Tomcat 7.0.37 and tested on Debian. The database was used in 
SQLite version 3.0 as a data storage program. The HTML-based web interface has 
been tested using Safari 6 and Chrome 22. The updated version of web browsers is 
recommended for the usage of the XDB. The flow chart for development of ‘Mass 
spectrometry-based glycan searching’, which is one of major query options 
















Figure 2.1 A flow chart for construction of ‘Mass spectrometry-based glycan 
searching’ in pig glycome database. 
 ４９ 
2.3 Pig glycome-human immune cell interaction study 
 
2.3.1 Preparation of WT and GalT-KO pig kidney glycans 
 
The protocol for the preparation of N-linked glycans derived from pig kidney 
is as chapter from 2.1.3 to 2.1.5. 
 
2.3.2 Isolation and culture of human immune cells 
 
Isolation and culture of human monocytes protocol was carried out following 
a previously described study [112] with minor modifications. Human mononuclear 
cells were isolated from buffy coats obtained from healthy donors using Ficoll-
Hypaque TM PLUS (GE Healthcare), followed by anti-CD14 microbeads magnetic 
cell sorting, according to the manufacturer’s instruction (Miltenyi Biotec/CLB, 
Amsterdam, The Netherlands). The CD14+ cells were seed in plastic six-well 
culture plates (3 x 106 cells/well) at 37°C in 10% FBS RPMI. For macrophage 
differentiation, GM-CSF (500 unit/mL) was added to the medium and incubated 
for 6 days. The cells were sub-cultured in 3 mL of 10% FBS RPMI culture media 
with treatment of pig glycans (WT and GalT-KO, respectively) from membrane 
fraction (2 mg) every 2 days. For mature macrophages, immature macrophages 
were incubated followed by stimulation with LPS (100 ug/mL) for one additional 
day. Dendritic cells were provided from Prof. Kyeong-Cheon Jung of Seoul 
National University College of Medicine. 
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2.3.3 FACS (Fluorescence-activated cell sorting) analysis 
 
Human immune cells were washed with PBS, and then incubated with PBS 
containing 5 mM EDTA for 5 min at 37°C to detachment from six-well culture 
plates and washed with 10% FBS RPMI. The washed cells then were stained with 
conjugated antibodies at 4°C for 30min. Intracellular expression of CD86, CD80, 
CD14, CD40, CD11b, and CD11c were access according to the manufacturer’s 
protocol. Data acquisition and processing was carried out using a FACSCalibur 
(BD Biosciences) and mean fluorescence intensities (MFI) were analyzed using 
FlowJo 7.5.5 software (Tree Star, Inc). 
 
2.3.4 Pig glycan-binding membrane protein screening from human immune 
cells 
 
Membrane proteins derived from dendritic cells were fractionated by the 
same method described in chapter 2.1.3. The glycan-immobilization protocol was 
carried out according to a previous study [106]. The prepared pig glycan and 
hydrazide core-shell beads (20 mg) were resuspended with 30% acetic acid, and 
then incubated at room temperature for 4 h. After the coupling reaction, pig glycan-
immobilized beads were washed with water five times The membrane fraction 
solution was incubated mock bead to prevent non-specific binding, and then the 
supernant was mixed with WT and GalT-KO pig kidney N-glycan-immobilized 
beads, respectively, at 37°C for 1 h. After washing with PBS three times, the 
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proteins were eluted with 0.2 M glycine-HCl buffer (pH 2.2). The eluted protein 
solution was neutralized with 1 M Tris-HCl buffer (pH 9.1). The proteins were 
denatured at 95°C for 3 min. After cooling down, the samples were mixed with 10 
μL of trypsin (1 μg/μL, Promega, Madison, WI, USA), and then incubated at 37°C 
for 16 h. Finally, the tryptic digested peptides were dried prior to proteomic 
analysis using MS. 
 
2.3.5 LC-MS/MS analysis 
 
MS/MS analysis was performed using LTQ FT Orbitrap mass spectrometer 
(Thermo Electron Corp, USA) equipped with a nano-electrospray ionization (NSI) 
source in positive mode at an ion spray voltage of 1.50 kV. 35% of normalized 
collisional energy and 2 Da of isolation width were used for tandem mass 
spectrometric fragmentation. The trypsin-digested protein fragments were injected 
into the nano LC (LC packing, Netherland)-MS/MS system. The loaded sample 
was eluted with gradient from 2% to 35% solvent B for 30 min, then from 35% to 
90% for 10 min, followed by 90% solvent B for 5 min, and finally 5% solvent B 
for 15 min at a flow rate of 300 nL/min. Solvent A was constituted in 
water/acetonitrile (98/2 [v/v]) and 0.1 % formic acid, and solvent B was constituted 
in water/acetonitrile (2/98 [v/v]) and 0.1 % formic acid. Data acquisition and 
processing were performed with BioWorks 3.2 software based on the SEQUEST 
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3.1 Qualitative and quantitative N-linked glycan analysis of WT and GalT-KO 
pig fibroblasts 
 
3.1.1 Isolation of homozygous GalT KO cells 
 
Fibroblasts with biallelic disruption of GalT gene due to LOH in heterozygous 
KO were obtained by the selection using IB4-Dynabead. As shown in Figure 3.1, 
PCR analysis confirmed that fibroblasts from the selected colony contained only 
GalT gene-targeted allele (9.2 kb) without having wild type allele (7.4 kb), 
demonstrating that homozygous KO fibroblasts were successfully isolated. 
 
3.1.2 MS profiling of N-linked glycans using MALDI-TOF MS 
 
This study sought to identify N-glycans on the cell surface of WT and GalT-
KO pig fibroblasts using MS-based approaches. The scheme of the approach used 
in this study is described as Figure 3.2. Cell membrane proteins were fractionated 
from pig fibroblast lysate by ultracentrifugation separation, and then N-linked 
glycans were released from the cell membrane proteins by peptide N-glycosidase F 
(PNGase F) digestion. Next, the released N-linked glycans were desalted using 
porous graphitic carbon (PGC) for solid-phase extraction. Finally, the purified N-
linked glycans were permethylated, and subsequently analyzed by MALDI-TOF 
MS and MS/MS.  
The representative mass spectra obtained from the WT and GalT-KO pig 




Figure 3.1 PCR analysis of homozygous GalT KO fibroblasts. Note that GalT-/-
fibroblasts contain only GalT gene-targeted alleles, whereas wild type alleles 





























Figure 3.3 Positive ion MALDI-TOF mass spectrum of the N-glycans isolated from pig (a) wild-type and (b) GT-
KO fibroblasts 
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totally 47 N-glycan including high-mannose type glycans and complex type 
glycans with bi-, tri-, and tetra-antennary structures on pig fibroblasts as 
summarized in Table 3.1. The predicted structures were proposed according to the 
structural information in our previous studies [55, 107]. The MS results also 
indicated that sialylated glycans as well as fucosylated glycans were the abundant 
components for complex type glycans. Notably, the α-Gal antigen considered as the 
major xenoantigen was not detected in Gal-KO pig fibroblasts, whereas this 
antigen (m/z 2652.4) was observed as a trace in WT. This α-Gal xenoantigen was 
deduced as two α-galactosylated bi-antennary glycan according to its molecular 
weight. It was also confirmed here that α-Gal-terminated N-glycan was absent on 
GalT-KO pig fibroblasts using MS. On the other hand, five N-linked glycans 
(observed at m/z value of 2186.2, 2822.5, 2996.6, 3445.8, and 3806.7) proposed as 
NeuGc-containing glycans were detected in both WT and GalT-KO pig fibroblasts. 
 
3.1.3 Quantitative analysis of N-linked glycans using solid-phase 
permethylation and MALDI-TOF MS 
 
To quantify N-linked glycan array on pig fibroblasts, MS-based quantitative 
analysis using solid-phase permethylation was carried out. As results, the relative 
quantities of and sialylated (92.3%) glycans in GalT-KO pig fibroblasts were 
higher than those in WT (69.9%) (Figure 3.4a). In addition, each N-glycan among 
total glycans using MS-based analysis combined with solid-phase permethylation 
is quantified. Most notably, a sialylated glycan composed of 
Hex5HexNAc4Fuc1NeuAc2 was dramatically elevated in the GalT-KO (14.2%) 
 ５９









Calc Expd Hex HexNAc Fuc NeuAc NeuGc WT GT-KO 
1 1579.8 1579.9 5 2 0 0 0 
 
13.3 (±0.60) 3.6 (±0.35) 
2 1590.8 1590.9 3 3 1 0 0 
 
2.1 (±0.15) 0.5 (±0.19) 
3 1620.8 1620.9 4 3 0 0 0 
 
1.1 (±0.28) trace  
4 1661.8 1661.9 3 4 0 0 0 
 
0.9 (±0.21) 0.6 (±0.23) 
5 1783.9 1784.0 6 2 0 0 0 
 
3.4 (±0.10) 0.5 (±0.31) 
6 1794.9 1795.0 4 3 1 0 0 
 
0.5 (±0.08) trace 
7 1824.9 1825.0 5 3 0 0 0 
 
0.6 (±0.09) trace 
 ６０
8 1835.9 1836.0 3 4 1 0 0 
 
1.6 (±0.15) 0.4 (±0.18) 
9 1865.9 1866.0 4 4 0 0 0 
 
0.4 (±0.12) trace 
10 1982.0 1982.1 4 3 0 1 0 
 
1.5 (±0.09) 1.0 (±0.35) 
11 1988.0 1988.1 7 2 0 0 0 
 
0.9 (±0.13) 0.3 (±0.08) 
12 1999.0 1999.1 5 3 1 0 0 
 
0.6 (±0.21) 0.1 (±0.05) 
13 2040.0 2040.1 4 4 1 0 0 
 
0.4 (±0.05) 0.2 (±0.02) 
14 2070.0 2070.1 5 4 0 0 0 
 
0.4 (±0.15) trace 
15 2186.2 2186.2 
4 3 1 0 1 
 
1.9 (±0.03) 1.2 (±0.18) 
5 3 0 1 0 
16 2192.1 2192.2 8 2 0 0 0 
 
0.7 (±0.19) 0.4 (±0.04) 
 ６１
17 2227.1 2227.2 4 4 0 1 0 
 
3.7 (±0.19) 2.0 (±0.31) 
18 2244.2 2244.3 5 4 1 0 0 
 
0.9 (±0.05) 0.3 (±0.02) 
19 2360.2 2360.3 5 3 1 1 0 
 
trace 0.4 (±0.10) 
20 2390.2 2390.3 6 3 0 1 0 
 
0.7 (±0.17) 0.3 (±0.24) 
21 2401.2 2401.3 4 4 1 1 0 
 
1.4 (±0.28) 1.4 (±0.09) 
22 2431.2 2431.3 5 4 0 1 0 
 
4.3 (±0.11) 3.5 (±0.22) 
23 2472.2 2472.4 4 5 0 1 0 
 
1.1 (±0.22) 0.7 (±0.04) 
24 2547.3 2547.4 5 3 0 2 0 
 
NDb 1.3 (±0.15) 
25 2605.3 2605.4 5 4 1 1 0 
 
0.3 (±0.08) 2.9 (±0.13) 
 ６２
26 2652.3 2652.4 7 4 1 0 0 
 
0.6 (±0.14) ND 
27 2676.3 2676.4 5 5 0 1 0 
 
0.4 (±0.19) 0.2 (±0.23) 
28 2764.4 2764.4 6 6 0 0 0 
 
1.4 (±0.26) 0.4 (±0.38) 
29 2792.4 2792.4 5 4 0 2 0 
 
17.2 (±0.42) 15.3 (±0.36) 
30 2822.4 2822.5 5 4 0 1 1 
 
1.8 (±0.36) 1.7 (±0.07) 
31 2880.4 2880.5 6 5 0 1 0 
 
0.3 (±0.04) 0.2 (±0.20) 
32 2966.5 2966.6 5 4 1 2 0 
 
1.5 (±0.10) 14.3 (±0.46) 
33 2996.5 2996.6 5 4 1 1 1 
 
0.2 (±0.17) 2.2 (±0.04) 
34 3037.5 3037.6 5 5 0 2 0 
 
3.6 (±0.25) 2.3 (±0.12) 
 ６３
35 3054.5 3054.5 6 5 1 1 0 
 
0.4 (±0.01) 0.9 (±0.11) 
36 3153.6 3153.6 5 4 0 3 0 
 
0.9 (±0.06) 0.8 (±0.34) 
37 3211.6 3211.7 5 5 1 2 0 
 
0.3 (±0.11) 0.4 (±0.38) 
38 3241.6 3241.7 6 5 0 2 0 
 
4.3 (±0.36) 3.9 (±0.03) 
39 3327.7 3327.7 5 4 1 3 0 
 
0.1 (±0.09) 0.4 (±0.00) 
40 3415.7 3415.7 6 5 1 2 0 
 
0.1 (±0.21) 2.5 (±0.49) 
41 3445.7 3445.8 6 5 1 1 1 
 
0.2 (±0.05) 0.2 (±0.16) 
42 3503.7 3503.7 7 6 1 1 0 
 
0.1 (±0.09) trace 
43 3602.8 3602.8 6 5 0 3 0 
 
20.9 (±0.26) 24.2 (±1.25) 
44 3776.8 3776.7 6 5 1 3 0 
 
ND 2.9 (±0.17) 
 ６４
45 3806.9 3806.8 6 5 1 2 1 
 
0.1 (±0.08) 0.5 (±0.07) 
46 3864.9 3864.8 7 6 1 2 0 
 
trace 0.7 (±0.06) 
47 3964.0 3963.9 6 5 0 4 0 
 
2.9 (±0.11) 3.3 (±0.14) 
a Quantitative sialylated and neutral N-glycan percentages measured by MALDI-TOF MS combined with solid-
phase permethylation. 





fibroblasts compared with WT (1.5%). In addition, Hex5HexNAc4Fuc1NeuAc1 
(2.9%) and Hex6HexNAc5Fuc1NeuAc2-3 (2.5% and 2.9%, respectively) glycans 
were also only observed or increased in the GalT-KO fibroblasts. This result 
indicated that Hex5HexNAc4Fuc1NeuAc2 bi-antennary N-linked glycan leads to an 
increase of total sialylation in GalT-KO pig fibroblasts. This study showed that 
these increased sialic acid-containing glycans, which contain a fucose 
monosaccharide, lead in an increase of the overall fucosylation level as well as 
sialylation on the pig GalT-KO as shown in Figure 3.4b. The current analysis also 
revealed that the quantity of NeuGc-containing N-linked glycan was slightly higher 
in the GalT-KO (6.1%) relative to the WT (4.5%) in Figure 3.4c. 
 
3.1.4 Qualitative analysis of N-linked glycans using MALDI-QIT-TOF MS/MS 
 
To validate N-linked glycan structures in pig fibroblasts, tandem mass 
spectrometry analysis was carried out using MALDI-QIT TOF MS. Above 
mentioned Hex5HexNAc4Fuc1NeuAc1-2 and Hex6HexNAc5Fuc1NeuAc2-3 glycans, 
the relative quantities of which are higher in GalT-KO pig fibroblasts than WT, 
were analyzed. As shown in Figure 3.5, the chemical structures of the glycans 
were elucidated through peak assignment of fragment ions in mass spectra and 
were therefore confirmed to be N-linked glycans which contain both sialic acid and 
fucose residues. For example, fragment ions at m/z 2230.2, 2591.4, 3040.3, and 
3401.4 were generated from parent ions at m/z 2605.4, 2966.6, 3415.7, and 3776.6, 
respectively, by the loss of an N-acetylneuraminic acid residue (375.2 Da) present 












Figure 3.4 Relative quantitative comparison of (a) sialylated N-glycans, (b) 
fucosylated N-glycans, and (c) NeuGc-containing N-glycan derived from pig 
fibroblasts using MALDI-TOF MS combined with solid-phase permethylation. The 


























Figure 3.5 Positive ion MS/MS spectra of permethylated sialylated N-linked 





1303.7 or 1317.7 corresponding to a fucosylated N-glycan core structure. In 
addition, NeuGc-containing N-glycans (Hex5HexNAc4NeuAc1NeuGc1 and 
Hex5HexNAc4Fuc1NeuAc1NeuGc1) were confirmed by MS/MS analysis (Figure 
3.6). For instance, fragment ions at m/z 2417.4 and 2591.3 were resulted from 




The α-Gal antigen considered as the major xenoantigen was not observed in 
Gal-KO pig fibroblasts, whereas this antigen was found as a trace in WT. The 
quantitative study on pig glycan showed that two α-Gal-terminated glycan with a 
core fucose (Hex7HexNAc4Fuc1) was identified as the most abundant α-Gal antigen 
among total α-Gal antigens on WT pig by both MS and HPLC analyses [106]. This 
study therefore suggested that this α-Gal antigen may be the major α-Gal antigen 
structure of N-linked glycans expressed on WT pig organs. On the other hand, five 
N-linked glycans proposed as NeuGc-containing glycans were detected in both WT 
and GalT-KO pig fibroblasts, indicating that NeuGc are still present on cell surface 
of pig fibroblasts after deletion of α-galactosyltransferase gene. Therefore, this 
NeuGc antigen may be the second major hurdle for further studies on pig-to-human 
as described previously [50]. For quantitation of N-linked glycan array on pig 
fibroblasts, MS-based quantitative analysis using solid-phase permethylation was 
performed in this study. MALDI-TOF MS combined with permethylation was 
reported as a good quantitative method in excellent correlation to the HPLC of 






Figure 3.6 Positive ion MS/MS spectra of permethylated NeuGc-containing N-








minimize sialic acid loss by oxidative degradation and peeling reaction and thus are 
more quantitative and efficient compared to conventional permethylation [114]. 
This study revealed that the relative quantities of and sialylated glycans in GalT-
KO pig fibroblasts were higher than those in WT, and therefore corresponded with 
recent studies on different organs of the GalT-KO pig [29, 106]. Park et al. 
reported that α1,3-galactosyltransferase deficiency in pigs increases sialic acid-
terminated glycoconjugates epitopes using enzyme-linked lectinosorbent assay. 
This lectin-based method was able to analyze on specific carbohydrate epitopes 
expressed on the cell surface, but did not provide quantitative information on 
individual glycans as well as these glycan structures of the GalT-KO pig.  
The current analysis revealed that a sialylated glycan composed of 
Hex5HexNAc4Fuc1NeuAc2 was dramatically elevated in the GalT-KO fibroblasts 
compared with WT. This result indicated that this N-linked glycan leads to an 
increase of total sialylation in GalT-KO pig fibroblasts. Interestingly, this study 
also showed that these increased sialylated glycans contains a fucose 
monosaccharide, and consequently these glycans took the lead in an increase of the 
overall fucosylation level as well as sialylation on the pig GalT-KO. A previous 
report showed there is no significant difference of fucose level between GalT-KO 
and WT pig fibroblasts [63]. However, in that study, overall cellular 
glycoconjugates include O-glycans and glycolipid-derived glycans as well as N-
glycan were measured by the lectin-based method. 
Some studies have reported to delineate various glycoconjugates in GalT-KO 
pig organs using lectin-based array [63, 115]. However, the detection and 
quantitative measurement of NeuGc has not been carried out because there is no 
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available lectin which specifically binds to the NeuGc epitope. Recently, Park et al. 
reported that quantification of NeuGc was performed by 1,2-diamino-4,5-
methylenedioxybenzene (DMB) derivatization of sialic acids, but did not 
distinguished the major glycan type such as N- and O-glycans and glycolipid-
derived glycans [29]. In the present study, glycan-specific analysis was performed 
using a glycan release method by enzyme, and thus it was possible to obtain the 
more detailed information regarding NeuGc-terminated N-glycans structure by MS 
analysis. The MS analysis revealed that the quantity of NeuGc-containing N-linked 
glycan was slightly higher in the GalT-KO relative to the WT. The increase of the 
NeuGc quantity on fibroblasts matched previous results on GalT-KO pig organs 
[29, 106], which showed that heart, liver, and kidney of the GalT-KO pigs had a 
higher level of NeuGc than the WT. Taken together, we concluded that sialic acid-
containing glycoconjugates including NeuGc antigen expression in pigs increase 
by deletion of α-galactosyltransferase gene. 
For validation of N-linked glycan structures in pig fibroblasts, tandem mass 
spectrometry analysis was carried out using MALDI-QIT TOF MS in this study, 
and consequently N-glycan structures were characterized. However, unfortunately, 
other N-glycans, which were expected to contain NeuGc residues, were difficult to 
be assigned because their peak intensities are too low to be isolated for MS/MS. 
Nevertheless, this study showed here that MS-based approach enabled qualitative 
and quantitative analysis of cellular N-glycan including xenoantigens from pig WT 




3.2 Comprehensive N-linked glycan analysis of GalT-KO pig kidney and 
comparative N-linked glycan profiling of WT and GalT-KO pig kidneys 
 
3.2.1 Strategy for N-linked glycan analysis 
 
The analytical scheme for N-glycome analysis used in this study is described 
as Figure 3.7. Cell membrane fractions were isolated from GalT-KO pig kidney 
tissues and then N-linked glycans were released from the membrane fractions by 
enzymatic N-deglycosylation. Ethanol precipitation was performed to remove N-
deglycosylated proteins and enzymes. After PGC purification, N-linked glycans 
were analyzed by multi-mass spectrometric analyses using MALDI-TOF MS and 
ESI-MS. This comprehensive MS-based glycomic approach allowed structural 
characterization and quantitation of total N-linked glycans on GalT-KO pig kidney. 
Both MALDI-TOF MS coupled with exoglycosidase sequencing, and ESI-MS/MS 
analysis enabled to elucidate N-linked glycan structures. MALDI-TOF MS analysis 
combined with solid-phase permethylation method permits comprehensive 
identification of both neutral and acidic glycans and therefore simultaneous 
quantitation of total N-linked glycans on GalT-KO pig kidney because the solid-
phase permethylation stabilized labile sialic acids by minimizing oxidative 
degradation and peeling reactions [93]. 
 
3.2.2 MS profiling of N-linked glycans using MALDI-TOF MS 
The representative MALDI-TOF mass spectra obtained from the GalT-KO pig 





























MS H HN F NA NG Iona Na ESI-MS 
MALDI- 
TOF MS 
Found Calc. Found Calc. 
- - 1345.7 1345.7 3 2 1 0 0   
 
- 1.4 (±0.22) MALDI-TOF MS 
1169.3 1169.3 - - 4 2 0 0 0 a 0 
 
1.4 - ESI-MS/MS 
- - 1416.7 1416.7 3 3 0 0 0   
 
- 0.7 (±0.15) MALDI-TOF MS 
1331.4 1331.4 1579.8 1579.8 5 2 0 0 0 a 0 
 




1356.4 1356.4 1590.8 1590.8 3 3 1 0 0 a 0 
 
2.2 0.8 (±0.20) 
MALDI-TOF MS 
ESI-MS/MS 
1372.4 1372.4 1620.8 1620.8 4 3 0 0 0 a 0 
 
1.0 0.4 (±0.17) 
MALDI-TOF MS 
ESI-MS/MS 
- - 1982.0 1982.0 4 3 0 1 0 - - 
 
- 0.3 (±0.11) MALDI-TOF MS 
 ７８
1413.5 1413.5 - - 3 4 0 0 0 a 0 
 
0.5 - ESI-MS/MS 
1493.5 1493.5 1783.9 1783.9 6 2 0 0  a 0 
 
5.0 2.7 (±0.09) 
MALDI-TOF MS 
ESI-MS/MS 
1518.5 1518.5 1794.9 1794.9 
4 3 1 
0  a 0 
 
0.9 0.6 (±0.05) 
MALDI-TOF MS 
ESI-MS/MS 
1711.6 1711.6 2156.0 2156.0 1  b 1 
 
0.7 0.5 (±0.19) 
MALDI-TOF MS 
ESI-MS/MS 
1534.5 1534.5 1824.9 1824.9 5 3 0 0  a 0 
 
0.9 0.7 (±0.07) 
MALDI-TOF MS 
ESI-MS/MS 
1727.6 1727.6 2186.1 2186.1 5 3 0 1  b 0 
 
0.7 0.6 (±0.18) 
MALDI-TOF MS 
ESI-MS/MS 
1559.5 1559.5 1835.9 1835.9 3 4 1 0  a 0 
 
0.8 0.4 (±0.22) 
MALDI-TOF MS 
ESI-MS/MS 
1575.5 1575.5 1865.9 1865.9 4 4 0 0  a 0 
 




1768.6 1768.6 - - 4 4 0 1  b 0 
 
0.5 - ESI-MS/MS 
1655.5 1655.5 1988.0 1988.0 7 2 0 0  a 0 
 
Major 
1.9 1.2 (±0.18) 
MALDI-TOF MS 
ESI-MS/MS 
1680.5 1680.5 1999.0 1999.0 5 3 1 0  a 0 
 
0.2 0.2 (±0.23) 
MALDI-TOF MS 
ESI-MS/MS 
1696.5 1696.5 2029.0 2029.0 6 3 0 0  a 0 
 
0.5 0.6 (±0.04) 
MALDI-TOF MS 
ESI-MS/MS 
- - 2390.2 2390.2 6 3 0 1    
 
 0.6 (±0.17) MALDI-TOF MS 
1721.6 1721.6 2040.0 2040.0 4 4 1 0  a 0 
 
1.3 1.6 (±0.03) 
MALDI-TOF MS 
ESI-MS/MS 
1914.7 1914.7 2401.2 2401.2 4 4 1 1  b 0 
 




1737.6 1737.6 2070.0 2070.0 5 4 0 0  a 0 
 
1.6 2.8 (±0.12) 
MALDI-TOF MS 
ESI-MS/MS 
1930.7 1930.7 2431.2 2431.2 5 4 0 1  b 0 
 




2792.4 2792.4 5 4 0 2 
 b 1 
 
8.5 2.9 (±0.05) ESI-MS/MS 
1110.4 1110.4  c 0 
1762.6 1762.6 - - 3 5 1 0  a 0 - 0.1 - ESI-MS/MS 
1817.6 1817.6 2192.1 2192.1 8 2 0 0  a 0 
 
0.8 0.9 (±0.06) 
MALDI-TOF MS 
ESI-MS/MS 
1873.7 1873.7 - - 5 3 1 1  b 0 
 
0.3 - ESI-MS/MS 
1883.6 1883.7 2244.1 2244.1 5 4 1 0  a 0 
 




2076.7 2076.7 2605.3 2605.3 5 4 1 1  b 0 
 
1.5 4.5 (±0.05) 
MALDI-TOF MS 
ESI-MS/MS 
- - 2635.3 2635.3 5 4 1 0 1 - - 
 
- 0.8 (±0.21) MALDI-TOF MS 
2389.8 2389.8 
2966.4 2966.4 5 4 1 2 
 b 1 
 
17.6 9.8 (±0.12) 
MALDI-TOF MS 
ESI-MS/MS 
1183.4 1183.4  c 0 
- - 2996.5 2996.5 5 4 1 1 1 - - 
 
- 1.3 (±0.09) MALDI-TOF MS 
1924.6 1924.6 2285.1 2285.1 4 5 1 0  a 0 
 
0.3 0.6 (±0.06) 
MALDI-TOF MS 
ESI-MS/MS 
2117.8 2117.8 - - 4 5 1 1  b 0 
 
0.1  ESI-MS/MS 
 ８２
1940.6 1940.6 2315.1 2315.1 5 5 0 0  a 0 
 
0.1 0.5 (±0.18) 
MALDI-TOF MS 
ESI-MS/MS 
2133.8 2133.8 - - 5 5 0 1  b 0 
 
0.1  ESI-MS/MS 
1979.6 1979.6 - - 9 2 0 0  a 0 
 
0.3  ESI-MS/MS 
2086.7 2086.7 2489.2 2489.2 5 5 1 0  a 0 
 
0.3 1.3 (±0.02) 
MALDI-TOF MS 
ESI-MS/MS 
2279.8 2279.8 2850.4 2850.4 5 5 1 1  b 0 
 
0.2 1.0 (±0.02) 
MALDI-TOF MS 
ESI-MS/MS 
1284.9 1284.9 3211.5 3211.6 5 5 1 2  c 0 
 




2102.7 2102.7 2519.2 2519.2 
6 5 0 




0.3 1.7 (±0.18) 
MALDI-TOF MS 
ESI-MS/MS 
2295.8 2295.8 2880.4 2880.4 1  b 0 
 
0.2 1.6 (±0.02) 
MALDI-TOF MS 
ESI-MS/MS 
1292.9 1292.9 3241.6 3241.6 2  c 0 
 
3.1 1.3 (±0.04) 
MALDI-TOF MS 
ESI-MS/MS 
- - 3602.7 3602.8 3  - - 
 
- 1.1 (±0.18) MALDI-TOF MS 
 ８４
2248.8 2248.8 2693.4 2693.4 
1 




0.5 5.2 (±0.08) 
MALDI-TOF MS 
ESI-MS/MS 
2441.9 2441.9 3054.5 3054.5 1 0 b 0 
 
0.3 5.5 (±0.28) 
MALDI-TOF MS 
ESI-MS/MS 
- - 3084.5 3084.5 0 1   
 




1366.0 1366.0 3415.6 3415.7 2 0 c 0 
 
Major 




- - 3445.6 3445.7 1 1   
 





3776.8 3776.9 3 




5.5 6.0 (±0.03) 
MALDI-TOF MS 
ESI-MS/MS 
1522.5 1522.5 0 c 1 
- - 3806.8 3806.9 2 1 - - 
 
- 1.0 (±0.08) MALDI-TOF MS 
 ８６
- - 2764.4 2764.4 6 6 0 0 0 - - 
 
- 0.6 (±0.09) MALDI-TOF MS 
- - 2938.5 2938.5 6 6 1 0 0 - - 
 
- 1.2 (±0.13) MALDI-TOF MS 
2467.8 2467.8 - - 
7 6 
0 





- - 3329.6 3329.7 1 0 - - 
 
- 1.1 (±0.02) MALDI-TOF MS 
1475.5 1475.5 3690.7 3690.8 2 0 c 0 
 
2.0 0.9 (±0.07) 
MALDI-TOF MS 
ESI-MS/MS 
1080.4 1080.4 - - 3  c 0 
 
trace  ESI-MS/MS 
2613.9 2613.9 3142.6 3142.6 1 0  a 0 
 




  3503.6 3503.7 1    
 
2.9 (±0.14) 
1548.5 1548.5 3864.8 3864.9 2  c 0 
 
4.0 2.4 (±0.23) 
MALDI-TOF MS 
ESI-MS/MS 





1149.1 1129.1 - - 3  d 0 
1705.1 1705.1 - - 3  c 1 





1850.6 1850.6 - - 4  c 1 
1861.6 1861.6 - - 4  c 2 
1731.1 1731.1 3952.8 3953.0 
8 7 1 
1 
2 







1250.8 1250.8 - - 3  d 0 0.7  ESI-MS/MS 
1372.5 1372.5 - - 
9 8 1 
3  d 0 
- 
0.5  ESI-MS/MS 
1469.6 1469.5 - - 
4 
 d 0 
0.1  ESI-MS/MS 
1477.1 1476.8 - -  d 1 
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profile of the GalT-KO pig kidney from the MALDI-TOF MS and ESI-MS results. 
The oligosaccharide compositions of hexoses (H), N-acetylhexosamines (HN), 
fucoses (F), N-acetylneuraminic acids (NA), and N-glycolylneuraminic acids (NG) 
were proposed based on their m/z values including adduct molecules. N-linked 
glycan profile of GalT-KO pig kidney revealed remarkable diverse N-linked glycan 
repertoire which is composed of both high-mannose type glycans and 
complex/hybrid type glycans as shown in Table 3.2. Many of complex type 
glycans were sialic acid or/and fucose-containing glycans. However, α-Gal antigen 
as a major carbohydrate antigen in xenotransplantation was not observed indicating 
that the α-Gal-containing N-glycan was not expressed on GalT-KO kidney. On the 
other hand, eight NeuGc-containing N-glycans [observed at m/z 2186.2 2635.2 
2880.3 2996.3 3026.4 3084.4 3445.4 3806.5 ([M + Na]+)] were found in this study, 
which has been considered as one of non-Gal antigens. This result indicated that 
there are still NeuGc antigens present on the pig tissues after knockout of α1,3-
galactosyltransferase gene. 
 
3.2.3 Structural analysis of N-linked glycans by exoglycosidase sequencing and 
ESI-MS/MS 
 
To validate the structure of N-linked glycans in GalT-KO pig kidney, 
enzymatic analysis using exoglycosidases was used in this study. First, it was 
confirmed the absence of α-Gal antigen on GalT-KO pig kidney using α-
galactosidase from green coffee bean. It was reported that a contaminating activity 
of β-galactosidase was not detected in the α-galactosidase according to the 
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manufacturer. Despite the treatment with this exoglycosidase, MALDI-TOF mass 
spectrum showed no mass shifts of oligosaccharide peaks (Figure 3.9), and thus 
indicated that the Galα1,3Gal residue of N-linked glycan was not expressed on 
GalT-KO pig kidney. In contrast to the α-galactosidase, β-galactosidase from 
bovine testis removed all non-reducing Gal residues from N-linked glycans 
(complex type glycans). β-hexosaminidase from S. pneumoniae reduced all 
oligosaccharides to the core structure of N-linked glycan with and without fucose 
(Man3GlcNAc2Fuc1 or Man3GlcNAc2). In contrast to the complex type glycans, 
there remained high-mannose type glycans which are resistant to activities of 
exoglycosidases used. This sequential exoglycosidase digestion with sialidase, with 
sialidase and β-galactosidase, and with sialidase, β-galactosidase, and β-
hexosaminidase allowed confirming the chemical structure of total N-linked 
glycans in GalT-KO pig kidney (Figure 3.10). 
The tandem mass spectrometry analysis using ESI-MS provides direct support 
for the enzymatic sequencing of oligosaccharide. Ion mobility was used to separate 
ions in different charged states and to reduce remaining contamination [116, 117]. 
Negative ion MS/MS spectra were recorded in the transfer cell and interpreted 
according to previous studies [118-121]. Fragments were formed by proton 
extraction from hydroxyl groups by the phosphate anion to give a [M-H]- ion 
which then fragments further to give the diagnostic ions. Unlike neutral glycans, 
sialylated glycans was less informative because ionization is mainly by direct loss 
of a proton from the carboxylic group of the sialic acid. Thus, for structural 
determination, an additional experiment was performed in which the sialic acids 









Figure 3.10 Validation of N-linked glycan structures on GalT-KO pig kidney by exoglycosidase sequencing 
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treated with acetic acid to remove sialic acids and the neutral glycans were 
examined by ESI-MS/MS. Neutral glycans were the same as in untreated sample 
showing that sialylated glycans were all derivatives of these compounds. As a 
result, mass fragmentation patterns of high-mannose type and complex/hybrid type 
glycans are consistent with our previous MS/MS results on WT pig kidney [106, 
107] except for α-Gal-terminated glycans. In the present study, there are no 1,3A4 
ions at m/z 586.4, which is the representative (or typical) α-Gal fragment ion 
(Hex2HexNAc-OCH=CHO
-) [122], indicating that α-Gal residue of N-linked 
glycans was not presented on GalT-KO pig kidney. Table 3.2 represents N-linked 
glycan structures identified by MS/MS analysis. 
 
3.2.4 Structural validation of non-Gal antigens using MALDI-QIT-TOF 
MS/MS and ESI-MS/MS 
 
The structures of NeuGc antigens were confirmed in GalT-KO pig kidney 
using tandem mass spectrometric analyses. The mass fragmentation pattern 
represents predominant b- and y-ions [nomenclature proposed by Domon and 
Costello [75]], which were produced from glycosidic bond cleavage, while cross 
ring fragment ions (a- and x-ions) are weak or absent in MALDI-QIT-TOF MS/MS. 
The representative MS/MS spectra are shown in Figure 3.11. The presence of 
NeuGc residue was validated by a diagnostic fragment b-ion at m/z 877.4 
corresponding to non-reducing NeuGcHexHexNAc. In addition, this MS/MS 
analysis revealed that there are apparently mono-NeuGc- containing N-linked 










Figure 3.11 Structural identification of NeuGc-containing N-glycans (m/z 2635.3, 2996.5, 3445.6, and 3806.8) by 
MALDI-QIT-TOF MS/MS 
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direct support for MALDI-TOF MS analysis. 
 
3.2.5 Quantitation of N-linked glycans using MALDI-TOF MS coupled with 
solid-phase permethylation and ESI-MS 
 
MALDI-TOF MS analysis combined with permethylation was previously 
reported as a good quantitative methodology [113]. Moreover, solid-phase 
permethylation was demonstrated to be more quantitative than the traditional 
permethylation [93]. Therefore, MALDI-TOF MS analysis combined with this 
derivatization method was used for pig N-glycome quantitation in this study. For 
more accurate quantitation, the relative level of oligosaccharides was measured 
from peak intensities of each oligosaccharide among peak intensities of total 
oligosaccharides. By integrating from the first to the third isotopic peak intensities, 
the peak intensity of each oligosaccharide was obtained. To identify glycosylation 
change by the deletion of α1,3-galactosyltransferase gene, N-glycan profiles on 
GalT-KO pig kidney was compared with our previous results on WT [106]. In 
contrast to WT, which showed a large array of α-Gal-containing glycans (35.2-
42.0% total N-linked glycans) (Table 3.3), the GalT-KO showed extensive sialic 
acid-containing glycan expression (58.0% total N-linked glycans) in Figure 3.12a. 
The previous analysis on WT identified sialic acid-containing N-glycans including 
NeuGc antigens, but failed to quantitatively measure the abundance of sialic acid-
terminated glycans because desialylated glycans were quantified. The present study 
made up for the direct comparison of sialylation between WT and GalT-KO by 
quantifying both sialylated glycans. As a result, the relative abundances of  
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Table 3.3 Relative quantitation of N-linked glycan types on GalT-KO pig kidney 



















sialylated glycans in GalT-KO were higher than those in WT (41.4% total N-linked 
glycans). MS analysis also revealed a slightly higher level of NeuGc-terminated N-
glycans on GalT-KO (7.9%) relative to the WT (3.7%) as shown in Figure 3.12b. 
In addition, the result revealed that the relative quantity of fucose-containing 





In xenotransplantation, the carbohydrate antigen as well as the protein antigen 
has been an important factor to induce immune rejections, and thus to overcome 
this xenograft failure. However, it is difficult to extensively profile the cellular 
glycome array expressed on the surface of non-human primates (e.g., pigs) due to 
structural diversity and complexity of the glycome. The present study reported on a 
qualitative and quantitative N-glycome analysis of GalT-KO pig kidney using MS-
based approaches. In addition, by integrating this study with our previous results 
regarding the WT pig [55], an in-depth comparison of N-glycomes between WT 
and GalT-KO pigs was carried out. Considering that cellular glycomes are complex 
and diverse repertoire as mentioned above, this comprehensive glycomic analysis 
would be an important approach for further glycobiology studies. 
Although GalT-KO non-human primates were produced for preventing HAR, 
there has been a controversy over the elimination of α-Gal antigens. A previous 
study demonstrated that the GalT-KO pig expressed low levels of α-Gal antigen, 






Figure 3.12 Comparative quantitation of (a) sialic acids and (b) NeuGc-containing 
N-glycans derived from WT and GalT-KO pig kidney tissues. The annotation with 
asterisks in this figure is as follows: ***: p < 0.001 
 
 １００
isoglobotriaosylceramide (iGb3; Galα1,3Galβ1,4Glcβ1Ceramid) as an alternative 
α-Gal antigen candidate in GalT-KO non-human primates [43, 44], suggesting that 
there are two different glycan processing pathway for the synthesis of Galα1,3Gal 
disaccharide [45]. Therefore, it is important to confirm the absence of terminal 
Galα1,3Gal residues in GalT-KO pig kidney. The current analysis showed here the 
complete absence of α-Gal antigens on GalT-KO pig kidney. The iGb3 glycolipid 
antigen was not observed as well because oligosaccharide release method was used 
to release N-linked glycans from proteins by PNGase F digestion. 
The increase or decrease of specific oligosaccharides is a significant 
consideration of oligosaccharide processing as well as presence or absence of them. 
This study enabled MS-based quantitative analyses of N-linked glycans derived 
from WT and GalT-KO pig kidneys as well as the identification of carbohydrate 
antigens. The current analysis revealed that abundance of sialic acid-terminated 
glycans is higher in GalT-KO relative to WT, and is there consistent with previous 
studies [29, 123]. However, due to limitations of lectin-based assay used, the 
previous studies did not explain the correlation of oligosaccharide structure with 
the oligosaccharide quantitative alteration. Here, the chemical structures of total N-
linked glycans in pig kidneys were identified, and were quantified relatively as 
shown in Table 3.2. The present study suggested that both α1,3-
galactosyltransferase and sialyltransferase competitively recognize an identical 
acceptor substrate which contains galactose of N-acetyllactosamine, and the 
activity of α1,3-galactosyltransferase is relatively higher than that of 
sialyltransferase in WT pigs. In contrast to the WT, sialyltransferases in GalT-KO 
may predominantly participate in the transfer of a sialic acid to a terminal exposed 
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galactose of N-acetyllactosamine because of the abolishment of α1,3-
galactosyltransferase activity, and therefore more sialic acid-linked glycans are 
present on GalT-KO. Interestingly, the current analysis also revealed that fucose 
level of N-linked glycans in GalT-KO is higher than WT. However, in contrast to 
the increase of sialic acid-linked glycans, it is less obvious that the relative quantity 
of N-linked glycans with a core fucose is increased in GalT-KO. This aberrant 
glycosylation, which is likely to be affected by perturbed oligosaccharide synthetic 
pathways, was observed in previous studies on GalT-KO pig organs [63, 115]. In 
addition, recent proteomics studies on GalT-KO primates showed that a wide 
variety of proteins changed their expression levels [30, 124]. Taken together, this 
study suggested that the deletion of α1,3-galactosyltransferase gene may influence 
the expression of other carbohydrate antigens including non-Gal antigens as well as 
the elimination of Galα1,3Gal residue. 
Another xenoantigenic carbohydrate, NeuGc (e.g., H-D antigen), has been 
regarded as one of non-Gal antigens participating in immune rejections. As noted 
above, although GalT-KO pigs were produced, there still remain NeuGc-containing 
oligosaccharides presented on pig cell surfaces, and the aberrant glycosylation on 
GalT-KO pig raises the possibility that the NeuGc level may change. This study, 
showed these NeuGc-containing N-glycans on GalT-KO pig kidney using MS. 
After α1,3-galactosyltransferase deficiency in pigs, some studies have progressed 
and reported to delineate GalT-KO pig glycome using lectin-based array, but failed 
to detect NeuGc antigen because there is no available lectin which is specific for 
the NeuGc residue [63, 115].`Recently, NeuGc residues, which used chemical 
reagent fluorescence labeling, were detected on GalT-KO pig organs [29]. However, 
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mass spectrometric analysis allowed for structural identification of these NeuGc 
antigens compared to the fluorescence detection. In addition, quantitative analysis 
revealed here that the level of NeuGc was higher in GalT-KO pig kidney relative to 
WT, and is therefore consistent with a previous study on GalT-KO pig tissues [29]. 
In the context of NeuGc biosynthesis, GalT-KO pigs showed a higher expression of 
NAD+-isocitrate dehydrogenase (IDH) [30], which is cytidine monophosphate-N-
acetylneuraminic acid hydroxylase (CMAH) cofactor. This CMAH enzyme is 
absent on humans and responsible for NeuGc biosynthesis [125]. Moreover, 
Saethre et al. demonstrated that the anti-HD antibodies specific for the NeuGc 
antigen accounted for a large proportion of anti-non-Gal antibodies in human sera, 
and these anti-HD antibody levels correlated with activation of GalT-KO pig 
endothelial cell [28]. Therefore, it should be emphasized that the NeuGc antigen is 













Chapter 4. Development of the database of  






















4.1 Pig glycome database and query in the database 
 
The relational pig glycome database was built up from specific pathogen-free 
Chicago Medical School miniature pig [126] glycan profiles, which have been 
qualitatively and quantitatively characterized by various mass spectrometry-based 
techniques. It includes N-glycomes from pig kidney [55], endothelial cells, islets 
[56], corneal endothelial cells, keratocytes [127], heart and glycosphingolipid-
derived glycans from pig endothelial cells and islets [54]. The O-glycomes from 
pig kidney, endothelial cells [58] and heart [57] are also included. 
Two major query options are implemented in the pig glycome database, 
namely, ‘pig tissue/cell specific glycans’ and ‘mass spectrometry-based glycan 
searching’. The ‘pig tissue/cell specific glycans’ option allows the retrieval of 
glycans derived from a specific pig tissue/cell. Users can obtain the full lists of 
glycans by clicking a specific pig organ or cell icon. It is also possible to set 
parameters including glycan epitope. On the other hand, the ‘mass spectrometry-
based glycan searching’ is a way to look for a specific glycan information from a 
mass-to-charge ratio (m/z). If the users input the experimental mass value (m/z), 
the program enables the users to gather the possible glycan structures and organs. 
In addition, the pig glycome database allows users to set a mass tolerance that can 
be specified in Daltons ± of the measured value to avert no search result found 
because of instrumental variations. The users can also narrow down the list of the 
glycans by specifying several factors. It includes the followings: mass spectrometry 
instrument, glycan derivatization method, glycan type, ion mode, ion adducts and 
origin, but it will be updated continuously.  
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4.2 Database content 
 
The search result from the pig glycome database contains mass value (m/z), 
derivatization, glycan type, structure, antigen, quantity and origin. The mass value 
is an experimental value of the corresponding glycan mass (mono-isotopic) 
analyzed using matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry or electrospray ionization mass spectrometry. The derivatization 
indicates the chemical derivatization for glycan analysis using mass spectrometry. 
All the glycans in the XDB are classified into three types: N-linked glycans (at the 
side chain of Asn), O-linked glycans (at the Ser/Thr residues) in glycoproteins and 
glycosphingolipid-derived glycans. Especially, the α-galactosylated glycans are 
labeled with ‘α-Gal antigen’ in the column of ‘Antigen type’. The chemical 
structures were drawn with Oxford glycan nomenclature [128]. The relative 
quantity of glycans, which was measured by NP-HPLC or quantitative MS analysis, 
was incorporated in the result table as well. Additionally, pie graphs represent the 
relative quantities of each type of glycans (e.g. high-mannose glycans, α-Gal 
glycans, sialylated glycans and so on). 
 
4.3 Use of the database program 
 
Examples of using pig glycome database 
There are two ways of searching for specific glycan information in XDB. One is a 
query on ‘Pig tissue/cell specific glycans’ and the other is on ‘Mass spectrometry-
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based glycan search’. 
(1) The following describes how to searching all N-glycans derive from pig 
endothelial cells using a query on ‘Pig tissue/cell specific glycans’.  
The user can set 4 parameters (species, glycan type, cell type and glycan epitope) 
before submitting a query or click a picture of pig endothelial cells for viewing the 
result. In this case, ‘pig’, ‘N-linked glycan’, ‘endothelial cells’ and ‘all’ were 
selected in species, glycan type, cell/tissue type and glycan epitope section, 
respectively.  Next, the user can click ‘submit’ button. Please refer to Figure 4.1. 
Once the query is submitted, the search result page is displayed (Figure 4.2). The 
search result page displays a table list and a pie graph. The table list contains mass 
to charge ratio value (m/z), derivatization, glycan type, structure, antigen, quantity 
and origin. The pie graph represents relative quantities of each type of glycans such 
α-Gal glycans, sialylated glycans 
(2) The following describes how to searching N-glycans having m/z 1809.6 
from pig organs using a query on ‘Mass spectrometry-based glycan search’. 
There are a number of parameters that have to be set before submitting a query 
(Figure 4.3). 
a. The user can enter a single mass to charge ratio (m/z) value to search against the 
database.  
b. The user can specify a mass tolerance threshold in Daltons +/- based on the mass 
accuracy of the user's instrument. Entering a number from 0.5 to 1.0 is 
recommended for an appropriate result. 










Figure 4.2 The search result page displaying pig endothelial cells N-glycans 










Figure 4.3 Pig glycome database interface showing the entered parameters for searching glycans having m/z 
1809.6 (adducted to sodium ion) analyzed by MALDI-TOF MS  
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MALDI-TOF MS and ESI-MS. 
d. The user can select one of three glycan types: N-glycan, O-glycan and 
glycolipid-derived glycan 
e. The user also can choose a derivatization method for analysis of glycans. If any 
derivatization methods were not used, ‘underivatised’ can be selected.  
f. Finally, The user has the option to search for ion mode (positive or negative) and 
the most common adducts (e.g. [M+Na]+ or [M+H2PO4]
-) obtained by ionization 
process in the  mass spectrometer.  
g. After all parameters have been set, the user click ‘search’ button. 
In this case, m/z value entered was 1809.6, the mass tolerance was set to 0.5 and 
MALDI-TOF MS in mass spectrometry was selected. Finally, the glycan type, 
derivatization and ion adduct selected were N-glycan, underivatization and 
[M+Na]+, respectively.  
Once the query is submitted, the search result page is displayed (Figure 4.4). The 
search result contains specified mass to charge ratio value (m/z), derivatization, 




Although many of the well-established glycan databases offer the detailed 
glycan structures, it is difficult to solely collect the pig glycans according to the 
specific organ or cell, which is a promising candidate for xenotransplantation. 
Therefore, in this study, an unique and specialized database have been built to 
provide reliable information on glycans, which are derived from tissues and cells of  
 １１１
 
Figure 4.4 The search result page displaying glycan, having m/z 1809.6 (adducted 















pigs. Moreover, it contains both qualitative and quantitative information on 
xenoantigenic glycans, which play an important role in immune-rejection response. 
Taken together, this database is potentially promising and facilitates 
xenotransplantation research as well as basic carbohydrate research. The pig 
glycome database will allow users to use hyperlink the human glycan database with 
Consortium for Functional Glycomics (CFG), which contains glycan profiles in 
human cells and tissues for pig-to-human xenotransplantation research. In the near 
future, this pig glycome database will be updated with a list of glycans from α1,3- 
galactosyltransferase gene-knock out pig samples as well. It will represent the 
quantitative visualization of WT and GalT-KO pig glycans according to some 
structural features. It includes the followings: glycan types (high-mannose type and 
complex/hybrid type), specific residue-containing glycans (sialylated glycan and 





































5.1 Assay for human immune cell activity against pig glycomes 
 
The N-linked glycans isolated from WT and GalT-KO pig kidney tissues were 
prepared, and then confirmed by using MALDI-TOF MS as described above. For 
detection of human cell activity against the pig N-linked glycans, expression levels 
of seven surface markers (CD86, CD80, CD40, CD11b, CD11c, CD14, and 
MHCII) on monocytes were assessed by FACS analysis (Figure 5.1). CD86, CD80, 
CD40 which was present on the surface of antigen-presenting cells (APCs) such as 
monocyte and dendritic cell, induce co-stimulatory signals for T-cell activation. 
CD11c is found at high levels on human dendritic cells, and thus serves as a human 
dendritic cell marker as well as MHCII, while CD11b acts as a macrophage marker. 
CD14 plays a role as a co-receptor against bacterial lipopolysaccharide (LPS). 
Expression levels of these surface markers on monocytes were compared after the 
treatment with N-linked glycans of WT and GalT-KO, respectively. The results 
represent no difference of the expression levels of the surface markers between WT 
and GalT-KO N-linked glycan treatments as shown in Figure 5.2. 
 
5.2 Screening of human immune cell proteins using pig glycan-immobilized 
beads 
 
For the high-throughput screening for human immune cell surface proteins 
interacting with pig glycans (Figure 5.3), a glycan immobilization method 
described previously [106] were used in this study. N-linked glycans derived from 









Figure 5.2 FACS analysis for expression levels of surface marker after the treatment of WT and GalT-KO pig 
glycans 
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WT pig kidney 
N-glycan immobilized beads
GT-KO pig kidney 
N-glycan immobilized beads
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protein analysis 




Figure 5.3 A strategy for screening and identification of human immune cell 














purification procedure as mentioned above, and were immobilized with 4-
hydrazinobenzoic acid (HBA)-functionalized HiCore beads by Schiff base 
formation, respectively. It was previously reported that the HiCore resin structure 
as a core-shell-type minimized non-specific protein binding [103]. Because the free 
reducing end of N-linked glycans formed as an aldehyde group was covalently 
conjugated with hydrazide group onto beads, this glycan-immobilization system 
allowed directional conjugation which enables the carbohydrate epitope to properly 
bind to the its protein receptor. In addition, the introduction of β-alanine-ε-
aminocaproic acid-β-alanine-ε-aminocaproic acid (BEBE) non-natural amino acid 
spacer between the glycan-HBA and the bead plays a role in preventing the steric 
hindrance in their interactions. Thus, this glycan-immobilized bead can be cell-
mimetic system covered by heterogeneous glycoconjugates. To investigate the 
interaction between pig glycan and human cell surface proteins, the human cell 
membrane fraction and pig glycan-immobilized beads were incubated and then the 
specific-binding tryptic-digested fraction was analyzed by LC-ESI-MS/MS. The 
results showed the some proteins were identified from human dendritic cells 





Understanding the interactions between pig xeno-carbohydrates and human 
immune cells can be approached from different perspective and is important for the 
advancement of basic science and drug development. A previous study reported on 
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Table 5.1 Identification of pig glycan-binding proteins from human dendritic cell using LTQ-FT MS. Max. XCorr 
is the highest XCorr value (>1.7, 2.5, and 3.0 for singly-, doubly-, and triply-charged ions respectively) for the 
detected peptides. 
Protein  WT   GalT-KO   
coverage 
(%) 
Max.Xcorr charge coverage 
(%) 
Max.Xcorr charge 
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the fishing-out of glycan-binding proteins in human serum using pig glycan-
immobilized beads [106]. The study developed a novel GBP screening technique 
combined with MS analysis, and these results showed identification of potential 
GBPs associated with pig-to-xenograft rejection, such as antibodies, cytokines, and 
complement components, etc. But, this approach has a minor limitation for GalT-
KO pig glycan study because of the use of alpha1,3-galactosidase on WT. Here, the 
present study tried to access to the interaction between GalT-KO pig glycome and 
human immune cells. However, a previous study demonstrated that enrichment of 
membrane proteins by conventional subcellular fractionation lead to identification 
of only a small amount of membrane proteins [129]. Moreover, these membrane 
proteins are largely contaminated with other subcellular proteins in cytosol and 
nucleus fractions etc. It may be also needed that sufficient human immune cells are 
provided from cell-line culture for the successful experiment. Therefore the 
identification of human cell surface proteins interacting with pig glycome remains 
challenge, and the complete characterization of pig glycan-specific interaction with 


































In xenotransplantation, although GalT-KO pigs have been produced as donors, 
there are still other xenoantigenic carbohydrates present on the surface of pig cells 
and tissues. These non-Gal antigens such as H-D antigen trigger AVR or DXR, and 
subsequence lead to the xenograft failure. Moreover, the targeted deletion of α1,3-
galactosyltransferase gene results in the perturbation of many other genes 
regardless of the α1,3-galactosyltransferase gene, and thereby leading to unknown 
phenotype effects such as an increase or decrease of other xenoantigen levels. 
Therefore, the identification of cellular glycome including non-Gal antigens is 
important to overcome the above mentioned obstacle.  
MS has recently become a powerful analytical tool for characterizing the 
oligosaccharide structures through tandem exoglycosidase digestion or mass 
spectrometric analysis. Moreover, MS approaches combined with diverse chemical 
derivatization of the oligosaccharides enabled to achieve reliable quantitation of the 
oligosaccharide. Both qualitative and quantitative analyses of glycans have results 
in a great number of glycome data, and thus it is essential to develop data 
repositories and software tools, which facilitate the annotation and interpretation of 
the big glycome data. 
This study presents an MS-based analysis for delineating of N-glycome 
repertoire derived from both WT and GalT-KO pig cells and tissues, and the 
comparison of the total N-glycomic profiles between WT and GalT-KO. In case of 
pig cells, total 47 N-glycan isolated from WT and GalT-KO pig fibroblasts was 
identified using MALDI-TOF MS analysis. In addition, MALDI-TOF MS analysis 
coupled with solid-phase permethylation allowed comparatively quantifying these 
N-linked glycans between WT and GalT-KO. The results showed that the relative 
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abundance of sialic acid-containing glycans increased in GalT-KO pig fibroblasts 
(92.3%) compared to WT (69.9%). MALDI-QIT-TOF MS/MS analysis indicated 
that Hex5HexNAc4Fuc1NeuAc2 bi-antennary N-glycan of sialylated glycans leads 
to an increase of total sialylated glycan level in GalT-KO pig fibroblasts. The 
current analysis showed NeuGc level was slightly higher in GalT-KO pig (6.1%) 
relative to WT (4.5%), suggesting that the deletion of α1,3-galactosyltransferase 
gene may not only remove construction of Galα1,3Gal residue but also increase 
sialylated glycans including NeuGc antigen. 
In case of pig kidney tissues, this study present the integrated MS-based 
approaches for the identification and quantitation of total N-linked glycans derived 
from GalT-KO pig kidney, and the comparative profiling of the N-glycans between 
WT and GalT-KO. N-linked glycans of GalT-KO pig kidney identified by 
complementary MS analyses using MALDI-TOF MS and ESI-MS instruments, 
showing remarkable complex N-linked glycan diversity including both high-
mannose type glycans and complex/hybrid type glycans. Most of complex type 
glycans were composed of sialylated or/and fucosylated glycans. Among the 
diverse glycan array on the GalT-KO pig kidney, it was confirmed that α-Gal 
antigen as a major carbohydrate antigen was absent by MALDI-TOF MS analysis 
coupled with α-galactosidase digestion. Total N-linked glycan structures are 
elucidated using ESI-MS/MS and MALDI-TOF MS combined with sequential 
exoglycosidase sequencing. Moreover, NeuGc-linked glycan structures regarded as 
a non-Gal antigen present on the pig GalT-KO pig kidney were initially validated 
by MALDI-QIT-TOF MS/MS analysis. For relative quantitation of N-linked 
glycans on GalT-KO, MALDI-TOF MS analysis combined with solid-phase 
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permethylation method was used. Unlike WT, which showed abundant α-Gal-
containing glycans (35.2-42.0% total N-linked glycans), the results showed that 
showed a large array of sialic acid-linked glycan expression (58.0% total N-linked 
glycans). The present analysis also revealed that the NeuGc level was higher in 
GalT-KO pig (7.9%) relative to WT (3.7%). This comprehensive glycomic analysis 
highlighted the unique total N-glycosylation characteristics of pig kidney tissues. 
Pig glycome database was developed here, which curates WT pig glycomes 
derived from various cells/tissues on pig. This database was designed as a user-
friendly web-based interface and is now available on the web 
(www.bioinformatics.snu.ac.kr/xdb) However, despite the importance of GalT-KO 
pig description for further xenotransplantation study in GalT-KO pig era, the pig 
glycome database has not yet included GalT-KO pig glycomes. Based on our 
present database platform, an advanced database will be present which contains 
structural and quantitative information on both WT and GalT-KO pig glycomes. In 
addition, this database allowed the relative comparison of glycome quantities 
between the WT and GalT-KO. In the near future, this database will be updated 
with other GalT-KO cells or/and tissues (e.g. GalT-KO fibroblasts) on pig as well 
as GalT-KO kidney.  
Furthermore, for understanding of interactions between pig carbohydrates and 
human immune cells, human immune cell activation against WT and GalT-KO pig 
glycans respectively, was measured by FACS analysis, and their proteins were 
screened and identified using glycan-immobilized beads and LC-MS/MS analysis. 
The results showed no difference of surface marker expression and pig glycan-
specific proteins associated with human immune cells between WT and GalT-KO 
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pig. The complete identification of interaction between pig glycans and human 
immune cells still remained to be solved for xenotransplantation studies. 
This work would like to emphasize on (1) establishment of the MS-based 
quantitative analysis as well as structural analysis of glycans (2) in-depth 
investigation for pig glycosylation on the WT and GalT-KO pig cell and tissue (3) 
the development of pig glycome database for comprehensive understanding of pig-
to-human xenotransplantation. Taken together, I anticipate that MS-based glycomic 
analysis and the relational pig glycome database will contribute in important 
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1. Processing of logic algorism source code 
 
 
class User < ActiveRecord::Base 
    has_secure_password 
 
    attr_accessible :login_id, :password, :password_confirmation 
 




class Molecule < ActiveRecord::Base 
  
attr_accessible :image,:ESImpz, :MALDImpzNa, :MALDImpzGT, :derivatiz
ation, 
      :glycan, :m_type, :quantity, :organ, :origin 
  mount_uploader :image, ImageUploader 
 
  def Mass() 
    if self.MALDImpzGT != 0 
      return self.MALDImpzGT 
    elsif self.MALDImpzNa != 0 
      return self.MALDImpzNa 
    elsif self.ESImpzNa != 0 
      return self.ESImpzNa 
    elsif self.ESImpzPO != 0 
      return self.ESImpzPO 
    end 
    return 0 
  end 
 
  def maldi_image 
    path = 'structure/' 
    path << self.Mass.to_s << '.png' 
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  end 
 
  def maldi_image_path 
    rails_path = "/xdb/assets/" 
    rails_path << maldi_image 
  end 
 
  def self.search(param) 
      search = {} 
      result = [] 
      if param[:search] 
          p 'Molecule\'s Search' 
          p param 
          if param[:Mass] 
              maldi = (param[:Mass_select] == 'MALDI-TOF MS') && 
(param[:ion_mode_tag] == 'MPNAP') 
              esi_PO   = (param[:Mass_select] == 'ESI-MS') && 
(param[:ion_mode_tag] == 'H2PO4') 
              esi_Na = (param[:Mass_select] == 'ESI-MS') && 
(param[:ion_mode_tag] == 'MPNAP') 
 
               
              gt = (param[:Mass_select] == 'MALDI-TOF MS') && 
                (param[:ion_mode_tag] == 'MPGTP') 
 
              unless maldi or esi_PO or esi_Na or gt 
                  return result, nil 
              end 
 
              mass_sel = :MALDImpzNa if maldi 
              mass_sel = :ESImpzPO if esi_PO 
              mass_sel = :ESImpzNa if esi_Na 
              mass_sel = :MALDImpzGT if gt 
              search[ mass_sel ] = (param[:Mass].to_f-
param[:tolerance].to_f).. 
                  (param[:Mass].to_f+param[:tolerance].to_f) 
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          end 
          search[:origin] = param[:origin] if param[:origin] 
          search[:derivatization] = param[:derivatization] if 
param[:derivatization] 
          search[:glycan] = param[:glycan] if param[:glycan] 
          search[:organ] = param[:organ] if param[:organ] 
 
          p 'Molecule\'s Search' 
          p search 
          if search.empty? then return result end 
          result = Molecule.where(search) 
      else 
          result = find(:all) 
      end 
      return result, mass_sel 
  end 
 
  def self.old_search(param) 
    if param[:search] 
      result = [] 
#      if param[:Mass_select].to_sym == :MALDImpzNa 
      if( param[:Mass_select] == 'MALDI-TOF MS')  
          unless ( param[:ion_mode_tag] == 'MPNAP') 
              return result; 
          end 
          mass_sel = :MALDImpzNa 
      elsif (param[:Mass_select] == 'ESI-MS') 
          unless ( param[:ion_mode_tag] == 'H2PO4') 
              return result; 
          end 
          mass_sel = :ESImpz 
      end 
      result = Molecule.where(mass_sel=> 
                              (param[:Mass].to_f-param[:tolerance].to_f).. 
                                  
(param[:Mass].to_f+param[:tolerance].to_f), 
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                             :origin => param[:origin], 
                             :derivatization => param[:derivatization], 
                             :glycan => param[:glycan]) 
#      if param[:Mass_select] == 'MALDI-TOF MS' 
#        result = Molecule.where(:MALDImpz => 
#          (param[:Mass].to_f-param[:tolerance].to_f).. 
#          (param[:Mass].to_f+param[:tolerance].to_f)) 
#         
##      elsif param[:Mass_select].to_sym == :ESImpz 
#      elsif param[:Mass_select]== 'ESI-MS' 
#        result = 
#          Molecule.where(:ESImpz => 
#          (param[:Mass].to_f-param[:tolerance].to_f).. 
#          (param[:Mass].to_f+param[:tolerance].to_f)) 
# 
#      end 
        result  
    else 
      find(:all) 
    end 
  end 
 
  def self.checkTolerance(data, _input, _tolerance) 
    input = BigDecimal.new(_input) 
    tolerance = BigDecimal.new(_tolerance) 
 
    if( -tolerance <= input - data && input - data <= tolerance) 
      return true 
    else 
      return false 
    end 
 





class Static::ExperimentalProtocolsController < 
ApplicationController 
 
  def document_id 
    :experimental_protocols 
  end 
 
  def kidney_n 
  end 
 
  def endo_islet_n 
  end 
 
  def endo_islet_g 
  end 
 
  def corneal_kerato_n 
  end 
 
  def kidney_endo_o 
  end 
 
  def heart_n 




class ApplicationController < ActionController::Base 
  protect_from_forgery 
   
  before_filter do |controller| 
    @current_document = nil 
    @current_document = controller.send(:document_id) if 
controller.respond_to?(:document_id) 
    @is_db_page = controller.respond_to?(:document_id) 
  end 
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  def db_page? 
    return @is_db_page 
  end 
 
  private 
  def current_user 
      @current_user ||= User.find(session[:user_id]) if 
session[:user_id] 
  end 
   
  def current_document 
    @current_document ||= nil 
  end 
  def current_document=(cu) 
    @current_document = cu 
  end 




class FlashImagesController < ApplicationController 
  def document_id 
    :glyco_profile 
  end 
  def index 
  end 
  def search 




class MoleculesController < ApplicationController 
 
  def document_id 
    :glyco_base 
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  end 
 
  def search 
 
    if params[:search] 
 
     @molecules, @mass_sel = Molecule.search(params) 
    else 
     @molecules = Molecule.all 
    end 
    #redirect_to :action => :index 
#    render :index 
    respond_to do |format| 
      format.html 
      format.json {render json: @molecules } 
    end 
  end 
   
  # GET /molecules 
  # GET /molecules.json 
  def index 
    #@molecules = Molecule.all 
 
    if params[:search] 
  
     @molecules = Molecule.search(params) 
    else 
     @molecules = Molecule.all 
    end 
    #@molecules = Molecule.search(params) 
 
    respond_to do |format| 
      format.html # index.html.erb 
      format.json { render json: @molecules } 
    end 
  end 
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  # GET /molecules/1 
  # GET /molecules/1.json 
  def show 
    @molecule = Molecule.find(params[:id]) 
 
    respond_to do |format| 
      format.html # show.html.erb 
      format.json { render json: @molecule } 
    end 
  end 
 
  # GET /molecules/new 
  # GET /molecules/new.json 
  def new 
    unless current_user  
         redirect_to root_url 
         return 
    end 
    @molecule = Molecule.new 
 
    respond_to do |format| 
      format.html # new.html.erb 
      format.json { render json: @molecule } 
    end 
  end 
 
  # GET /molecules/1/edit 
  def edit 
    unless current_user  
         redirect_to root_url 
         return 
    end 
    @molecule = Molecule.find(params[:id]) 
  end 
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  # POST /molecules 
  # POST /molecules.json 
  def create 
    unless current_user  
         redirect_to root_url 
         return 
    end 
    @molecule = Molecule.new(params[:molecule]) 
    p params[:molecule] 
    p @molecule 
 
    respond_to do |format| 
      if @molecule.save 
        format.html { redirect_to @molecule, notice: 'Molecule was 
successfully created.' } 
        format.json { render json: @molecule, status: :created, 
location: @molecule } 
      else 
        format.html { render action: "new" } 
        format.json { render json: @molecule.errors, 
status: :unprocessable_entity } 
      end 
    end 
  end 
 
  # PUT /molecules/1 
  # PUT /molecules/1.json 
  def update 
    unless current_user  
         redirect_to root_url 
         return 
    end 
    @molecule = Molecule.find(params[:id]) 
 
    respond_to do |format| 
      if @molecule.update_attributes(params[:molecule]) 
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        format.html { redirect_to @molecule, notice: 'Molecule was 
successfully updated.' } 
        format.json { head :ok } 
      else 
        format.html { render action: "edit" } 
        format.json { render json: @molecule.errors, 
status: :unprocessable_entity } 
      end 
    end 
  end 
 
  # DELETE /molecules/1 
  # DELETE /molecules/1.json 
  def destroy 
    unless current_user  
         redirect_to root_url 
         return 
    end 
    @molecule = Molecule.find(params[:id]) 
    @molecule.destroy 
 
    respond_to do |format| 
      format.html { redirect_to molecules_url } 
      format.json { head :ok } 
    end 




class SessionsController < ApplicationController 
  def new 
  end 
 
  def create 
      user = User.find_by_login_id(params[:email]) 
      if user && user.authenticate(params[:password]) 
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          session[:user_id] = user.id 
          redirect_to root_url, notice: "Logged in!" 
      else 
          flash.now.alert = "Email or password is invalid" 
           render action: "new"  
      end 
  end 
 
  def destroy 
      session[:user_id] = nil 
      redirect_to root_url, notice: "logged out!" 





class StaticPagesController < ApplicationController 
  def index 
  end 
  def about 




class UsersController < ApplicationController 
 




class MetaDataController < ApplicationController 
  def document_id 
    :meta_data 
  end 
 
  def meta_data 
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  end 
 
  def default 
    @doc_name = params[:doc_name] 
  end 
 
#  def kidneyN 
#  end 
# 
#  def endoNisletN 
#  end 
# 
#  def endoGisletG 
#  end 
# 
#  def corNkeraN 
#  end 
# 
#  def kidneyOendoO 
#  end 
# 
#  def heartN 






















    def custom_humanize( string ) 
      string[0] = string[0].capitalize 
      return string 
    end 
    def zero_to_empty( int ) 
        if int == 0.0 
            return '' 
        else 
            return int 
        end 












# encoding: utf-8 
 
class ImageUploader < CarrierWave::Uploader::Base 
 
  # Include RMagick or MiniMagick support: 
   include CarrierWave::RMagick 
  # include CarrierWave::MiniMagick 
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  # Choose what kind of storage to use for this uploader: 
  storage :file 
  # storage :fog 
 
  # Override the directory where uploaded files will be stored. 
  # This is a sensible default for uploaders that are meant to be 
mounted: 
  def store_dir 
    
"uploads/#{model.class.to_s.underscore}/#{mounted_as}/#{model.id}" 
  end 
 
  # Provide a default URL as a default if there hasn't been a file 
uploaded: 
  # def default_url 
  #   "/images/fallback/" + [version_name, 
"default.png"].compact.join('_') 
  # end 
 
  # Process files as they are uploaded: 
  # process :scale => [200, 300] 
  # 
  # def scale(width, height) 
  #   # do something 
  # end 
 
  # Create different versions of your uploaded files: 
   version :thumb do 
     #process :scale => [50, 50] 
     process :resize_to_limit => [50,50] 
   end 
 
  # Add a white list of extensions which are allowed to be uploaded. 
  # For images you might use something like this: 
  # def extension_white_list 
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  #   %w(jpg jpeg gif png) 
  # end 
 
  # Override the filename of the uploaded files: 
  # Avoid using model.id or version_name here, see uploader/store.rb 
for details. 
  # def filename 
  #   "something.jpg" if original_filename 





























2. Construction of web page 
 
 
<%= form_for @molecule, :html => {:multipart => true} do |f| %> 
  <% if @molecule.errors.any? %> 
    <div id="error_explanation"> 
      <h2><%= pluralize(@molecule.errors.count, "error") %> 
prohibited this molecule from being saved:</h2> 
 
      <ul> 
      <% @molecule.errors.full_messages.each do |msg| %> 
        <li><%= msg %></li> 
      <% end %> 
      </ul> 
    </div> 
  <% end %> 
 
  <div class="field"> 
    <%= f.label :MALDImpz %><br /> 
    <%= f.text_field :MALDImpz %> 
  </div> 
  <div class="field"> 
    <%= f.label :ESImpz %><br /> 
    <%= f.text_field :ESImpz %> 
  </div> 
  <div class="field"> 





    <%#= f.check_box :derivatization %> 
  </div> 
  <div class="field"> 
    <%= f.label :glycan %><br /> 
   <%= f.select(:glycan, options_for_select( 
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 %w(N-glycan O-glycan glycan\ from\ glycolipid), 
@molecule.glycan))%> 
  </div> 
  <div class="field"> 
    <%= f.label :type %><br /> 
    <%= f.text_field :m_type %> 
  </div> 
  <div class="field"> 
    <%= f.label :quantity %><br /> 
    <%= f.text_field :quantity %> 
  </div> 
  <div class="field"> 
 <%= f.label :origin%><br /> 
 <%= f.select(:origin, options_for_select( 
 %w(human pig other\ mammalia plant fungi), 
@molecule.origin))%> 
  </div> 
  <div class="field"> 
    <%= f.label :organ %><br /> 
 <%= f.text_field :organ %> 
  </div> 
  <div class="field"> 
      <%= f.file_field :image %> 
  </div> 
  <div class="actions"> 
    <%= f.submit %> 
  </div> 
<% end %> 
 
 
<!-- <h2 class='alt'> --> 
<!--h3> 
Pig Glycan Database is a tool that can receive pig glycan 
information (glycan type, predicted structure, and so on) from their 
experimentally determined masses. The program can be used for free 






<% if current_user %> 






<%= render 'form' %> 
 
<%= link_to 'Show', @molecule %> | 
<%= link_to 'Back', molecules_path %> 
 
 
<div class="container db"> 
 
<div class="span22 prepend-1"> 




<div class="span22 prepend-1" style="font-size:120%"> 
 <%= render "search_form"%> 
 <br class="space"/> 
 <br class="space"/> 
 <br class="space"/> 
</div> 
 
<div class="span22 prepend-1"> 
 <%= render 'new_molecule'%> 
 <br class="space"/> 
 <br class="space"/> 










<%= render 'form' %> 
 







 <div class="span-22 prepend-1 append-1"> 
                <a name='search-result'></a> 
  <h3>Search Result</h3> 
 </div> 
  
 <div class="span-24"> 
  <div class="border"> 
  <%= render "search_result"%> 
  </div> 





 <div class="span-22 prepend-1 append-1"> 
  <h3>Search</h3> 
  <%= render "search_form" %> 





 <div class="span-22 prepend-1 append-1"> 
  <br class="space"> <br class="space"> 
  <%= render "new_molecule"%> 
 </div> 
 
 <div class="span-22"> 






<% content_for :stylesheets do %> 
    img.structure { 
        width: 132px; 
        height: 60px; 
        max-width: none; 
    } 
<% end %> 
 
 
<p id="notice"><%= notice %></p> 
 
<p> 
  <b>Maldimpz:</b> 




  <b>Esimpz:</b> 





  <b>Derivatization:</b> 




  <b>Glycan:</b> 




  <b>Type:</b> 




  <b>Quantity:</b> 




  <b>Organ:</b> 




  <b>Origin:</b> 




    <%= image_tag @molecule.image_url if @molecule.image? %> 
</p> 
 
<%= link_to 'Edit', edit_molecule_path(@molecule) %> | 






  <%= image_tag 'pig.jpg', :id => 'pig' %> 
  <div id='kidney'      class='clickable' > </div> 
  <div id='liver'       class='clickable' > </div> 
  <div id='islet'       class='clickable' > </div> 
  <div id='heart'       class='clickable' > </div> 
  <div id='eye'         class='clickable' > </div> 





<div id="eye_dialog" title="choose one"> 
  <button id='b_corneal'>corneal endothelial cell</button> 
  </br> </br> 
  <button id='b_kerato'>keratocyte</button> 
</div> 
<div id="heart_dialog" title="choose one"> 
  <button id='b_aortic_valve'>aortic valve</button> 
  </br> </br> 
  <button id='b_pulmunary_valve'>pulmonary valve</button> 
  </br> </br> 
  <button id='b_aortic_wall'>aortic wall</button> 
  </br> </br> 
  <button id='b_pulmunary_wall'>pulmonary wall</button> 
  </br> </br> 
  <button id='b_muscle'>muscle</button> 
  </br> </br> 




<select name="effects" id="effectTypes"> 
  <option value="blind">Blind</option> 
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  <option value="bounce">Bounce</option> 
  <option value="clip">Clip</option> 
  <option value="drop">Drop</option> 
  <option value="explode">Explode</option> 
  <option value="fold">Fold</option> 
  <option value="highlight">Highlight</option> 
  <option value="puff">Puff</option> 
  <option value="pulsate">Pulsate</option> 
  <option value="scale">Scale</option> 
  <option value="shake">Shake</option> 
  <option value="size">Size</option> 
  <option value="slide">Slide</option> 
</select> 
 




<div class="span-22 prepend-1" > 
 <br /><br /><br /> 
 
  <%= image_tag 'graph/kidney_n.jpg',  
    :class => 'g_hidden graph g_kidney'%> 
 
  <%= image_tag 'graph/corneal_endothelial_cell_n.jpg', 
    :class => 'g_hidden graph g_corneal' %> 
 
  <%= image_tag 'graph/keratocyte_n.jpg', 
    :class => 'g_hidden graph g_keratocyte' %> 
 
  <%= image_tag 'graph/pancreatic_islet_cell_n.jpg', 
    :class => 'g_hidden graph g_islet' %> 
  <%= image_tag 'graph/pancreatic_islet_cell_glycolipid.jpg', 
    :class => 'g_hidden graph g_islet' %> 
 
  <%= image_tag 'graph/heart_pericandium_n.jpg', 
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    :class => 'g_hidden graph g_pericardium' %> 
 
  <%= image_tag 'graph/heart_pulmunary_valve_n.jpg', 
    :class => 'g_hidden graph g_pul_valve' %> 
 
  <%= image_tag 'graph/heart_pulmunary_wall_n.jpg', 
    :class => 'g_hidden graph g_pul_wall' %> 
 
  <%= image_tag 'graph/heart_muscle_n.jpg', 
    :class => 'g_hidden graph g_muscle' %> 
 
  <%= image_tag 'graph/heart_aortic_valve_n.jpg', 
    :class => 'g_hidden graph g_aortic_valve' %> 
 
  <%= image_tag 'graph/heart_aortic_wall_n.jpg', 
    :class => 'g_hidden graph g_aortic_wall' %> 
 
  <%= image_tag 'graph/endothelial_cell_n.jpg', 
    :class => 'g_hidden graph g_endothelial'%> 
  <%= image_tag 'graph/endothelial_cell_glycolipid.jpg', 
    :class => 'g_hidden graph g_endothelial'%> 






  <p> 
    <h5> 
      1. Key to structural symbols in this and other figures: ■ 
GlcNAc, ○ mannose, ◊ galactose, ◈ fucose. The angles of the lines 
joining the symbols denote linkage: │ 1-2,  ∕ 1-3, ━ 1-4, and 
＼ 1-6. Full line beta-linkage, broken lines alpha-linkage. 
      <br /> 
      2. Some of these glycans have isomeric structures or different 
structures. Additional information can be found in our previous 
 １６８
reports. 
      <br /> 
      3. The ions of GT-derivatized glycans are [M+GT]+ in MALDI-TOF 
MS. 
      <br /> 
      4. The ions (< m/z 1727.0) of sialic acids are doublet charged 
([M-2H]2-) in ESI-MS within our dataset. 
      <br /> 
    </h5> 




<div class="container db"> 
 
  <div class="span-10 prepend-6"> 
    <div class="field" style="font-size: 120%"> 
      <%= label_tag :species %> 
      <%= select_tag("species", options_for_select( 
        [%w(Pig pig)], params[:species]))%> 
 
      </br> 
      <%= label_tag :glycan_type%> 
      <%= select_tag("glycan", options_for_select( 
        [%w(N-linked\ glycan N-glycan), 
        %w(O-linked\ glycan O-glycan), 
        %w(Glycolipid-derived\ glycan glycolipid-derived\ glycan)], 
        params[:glycan_type]))%> 
 
      </br> 
      <%= label_tag :cell_type%> 
      <%= select_tag("cell type", grouped_options_for_select( 
        { 
          'Tissue' => [%w(Kidney kidney), 
                        %w(Heart heart), 
                        %w(-aortic\ valve aortic\ valve), 
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                        %w(-pulmonary\ valve pulmonary\ valve), 
                        %w(-pulmonary\ wall pulmonary\ wall), 
                        %w(-aortic\ wall aortic\ wall), 
                        %w(-muscle muscle), 
                        %w(-pericardium pericardium), 
                      ], 
          'Cell'   => [  
                         %w(Endothelial\ cell endothelial\ cell), 
                         %w(Pancreatic\ islet\ cell 
pancreatic\ islet\ cell), 
                         %w(Keratocytes keratocyte), 
                         %w(Corneal\ endothelial\ cell  
                            corneal\ endothelial\ cell), 
                       ] 
        } 
      ))%>  
 
    </br> 
      <%= label_tag :glycan_epitope %> 
      <%= select_tag("glycan epitope", options_for_select( 
              [%w(all), 
              %w(alpha-Gal antigen), 
              %w(sialylation), 
              %w(-N-acetylneuraminic\ acid-terminated), 
              %w(-Hanganutziu-Deicher\ antigen), 
              %w(high-mannose), 
              %w(fucosylation), 
              %w(-core\ fucosylation), 
              %w(-outer-arm\ fucosylation)] 
      )) %> 
    </br> 
    <%=button_tag(:type => 'button', :id => 'search_button') do %> 
      <% 'submit' %> 
    <% end %>  
    </br> </br> 
    </div> 
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  </div> 
 
  <div class="span-24 image_description"> 
    <p> 
      <h5>Key to structural symbols in this and other figures: ★ 
NeuAc, ☆ NeuGc, ■ GlcNAc, ○ mannose, ◊ galactose, ◈ fucose. The 
angles of the lines joining the 
        symbols denote linkage: l 1-2, / 1-3, — 1-4, and \ 1-6. 
      </h5> 
    </p> 
  </div> 
 
  <div> 
    <%= render "ajax_table"%> 
  </div> 
 
  <div class="demo span-22"> 
 
      <%#= render :partial => 'effect' %> 
 
  </div><!-- End demo --> 
 




<div class="span-24 image_description"> 
  <p> 
    <h5> 
        1. Some of these glycans have isomeric structures or 
different structures. Additional information can be found in our 
previous reports. 
    </h5> 
 
 
    <h5> 
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        2. The ions of GT-derivatized glycans are [M+GT]+ + in MALDI-
TOF MS. 
    </h5> 
 
 
    <h5> 
      3. The ions (< m/z 1727.0) of sialic acids are doublet charged 
([M-2H]2-) in ESI-MS within our dataset. 
    </h5> 
  </p> 
</div> 
 
<div class="span-22 support_link "> 
  <h5> 
    Access to supporting experimental 
    <ul> 
      <li><a href='http://www.ncbi.nlm.nih.gov/pubmed/18546155'> 
Kidney N-glycan</a></li> 
      <li><a href='http://www.ncbi.nlm.nih.gov/pubmed/19373860'> 
Endothelial and islet cell (N-glycan)</a></li> 
      <li><a 
href='http://www.ncbi.nlm.nih.gov/pubmed/19760646'>Endothelial and 
islet cell (glycolipid-derived glycan) </a></li> 
      <li><a 
href='http://www.ncbi.nlm.nih.gov/pubmed/19895316'>Corneal 
endothelial cell and keratocytes (N-glycan)</a></li> 
      <li><a 
href='http://www.ncbi.nlm.nih.gov/pubmed/23399746'>Kidney and 
endothelial cell (O-glycan)</a></li> 
      <li><a href='http://www.ncbi.nlm.nih.gov/pubmed/22808845'>Heart 
(N-glycan) </a></li> 
    </ul> 
    <!--<a href='http://www.ncbi.nlm.nih.gov/pubmed/18546155' 
class='support_link Kidney N-glycan'> Access to supporting 
experimental data Kidney (N-glycan)<br /></a>--> 
    <!--<a href='http://www.ncbi.nlm.nih.gov/pubmed/19373860' 
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class='support_link endothelial islet N-glycan' >Access to 
supporting experimental data Endothelial and islet cell (N-
glycan)<br /></a>--> 
    <!--<a href='http://www.ncbi.nlm.nih.gov/pubmed/19760646' 
class='support_link endothelial islet' >Access to supporting 
experimental data Endothelial and islet cell (glycolipid-derived 
glycan)<br /></a>--> 
    <!--<a href='http://www.ncbi.nlm.nih.gov/pubmed/19895316' 
class='support_link corneal keratocytes N-glycan' >Access to 
supporting experimental data Corneal endothelial cell and 
keratocytes (N-glycan)<br /></a>--> 
    <!--<a href='http://www.ncbi.nlm.nih.gov/pubmed/23399746' 
class='support_link endothelial  Kidney O-glycan' >Access to 
supporting experimental data Kidney and endothelial cell (O-
glycan)<br /></a>--> 
    <!--<a href='http://www.ncbi.nlm.nih.gov/pubmed/22808845' 
class='support_link heart N-glycan' >Access to supporting 
experimental data Heart (N-glycan)</a>--> 
  </h5> 
</div> 
 




    <div class='span-22'> 
        <%= render 'clickable_images' %> 
    </div> 
 
    <div class="span-22"> 
        <br class="space"/> 
        <br class="space"/> 
        <br class="space"/> 
        <br class="space"/> 
        <br class="space"/> 
        <br class="space"/> 
 １７３
        <br class="space"/> 
        <br class="space"/> 
        <br class="space"/> 
        <br class="space"/> 
        <br class="space"/> 
        <br class="space"/> 
    </div> 
</div> 
 
<% content_for :stylesheets do %> 
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    } 
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    } 
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    } 
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    } 
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 #mother_image { 
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                margin-bottom:7px; 
                width: 505px; 
                height: 386px; 
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 } 
 #pig { 
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  top:0px; 
        width: 100%; 
        z-index:-1; 
 } 
 #kidney { 
  position:absolute; 
  top:0%; 
  left:45%; 
        width: 20%; 
        height: 30%; 
 } 
 #liver { 
  position:absolute; 
  top:8%; 
  left:76%; 
        width: 24%; 
        height: 29%; 
 } 
 #heart { 
  position:absolute; 
  top:69%; 
  left:45%; 
        width: 21%; 
        height: 33%; 
 } 
 #islet { 
  position:absolute; 
  top:67%; 
  left:5%; 
        width: 25%; 
        height: 28%; 
 } 
 #eye { 
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  left:1%; 
        width: 30%; 
        height: 30%; 
 } 
    #endothelial { 
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    top:68%; 
    left:76%; 
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    height: 29%; 
    } 
 
    .alpha_antigen { 
            color: #FF2020; 
    } 
 
    .neu_antigen { 
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    } 
 
 #draggable { width: 150px; height: 150px; padding: 0.5em; 
color: #ccc;} 
 #feedback { font-size: 1.4em; } 
 #selectable .ui-selecting { background: #FECA40; } 
 #selectable .ui-selected { background: #F39814; color: 
white; } 
 #selectable { list-style-type: none; margin: 0; padding: 0; 
width: 60%; } 
 #selectable li { margin: 3px; padding: 0.4em; font-size: 
1.4em; height: 18px; } 
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  #right_menu {float: right; background-color: yellow; color: black} 
--> 









<%= form_tag sessions_path do %> 
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본 연구에서는, 인간으로 이종장기이식의 유망한 기증동물로 
여겨지고 있는 α-Gal 당질항원의 합성효소 유전자를 제거한 돼지 (α1,3-
galactosyltransferase gene-knockout, GalT-KO) 의 세포와 조직을 대상으로 
면역거부반응과 관련된 당에 대한 질량 분석기 기반의 정성 및 정량적 
분석 연구를 수행하였다. 
첫째, 야생주 돼지와 GalT-KO 돼지 세포 표면에 발현된 N-
글라이칸들의 구조와 양을 비교하였다. 고체 상태 완전메틸화 방법을 
결합한 매트릭스 보조 레이저 탈착 이온화 (MALDI) 질량 분석 기법을 
이용하여 야생주 돼지와 GalT-KO 돼지의 섬유아세포 표면의 N-
글라이칸의 구조 및 정량적 차이를 규명할 수 있었다. 이 결과를 통해 
α-Gal 당질항원의 합성효소 유전자 제거는 돼지 세포 표면의 α-Gal 
당질항원의 제거뿐만 아니라, 돼지 다른 당질항원을 포함한 전체적인 
당의 발현 정도에 영향을 준다는 것을 확인할 수 있었다. 
둘째, GalT-KO 돼지에서 실제 인간으로 이종이식의 직접적 대상이 
되는  간  조직으로부터  N-글라이칸들의  구조  및  정량  분석을  통해 
야생주 돼지의 간 표면의 N-글라이칸들과 비교하였다.  MALDI 질량 
분석기와 전기분사 이온화 (ESI) 질량 분석기의 상호보완적 분석기법을 
이용하여 GalT-KO 돼지 표면의 당들에서 α-Gal 당질항원이 제거된 것을 
확인하였고, 면역거부반응을 일으키는 non-Gal 당질항원으로 알려진 N-
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글 라 이 코 릴 뉴 라 미 닉 산 이  존 재 하 는  것 을  확 인 하 였 다 .  말 단 당 
가수분해효소를  이용한  시퀀싱과  ESI 질량  분석기를  이용한  텐덤 
질량분석 기법을 통해 이들 GalT-KO 돼지 간 조직 표면에 발현된 모든 
N-글라이칸들의 구조를 규명하였다. 특히, MALDI-quadropole 이온 트랩 
질량  분석기법을 통해 N-글라이코릴뉴라미닉산들의  구조를 새롭게 
규명할  수  있었다 .  그리고  당의  구조적  분석과  더불어  고체  상태 
완전메틸화를 결합한 MALDI 및 ESI 질량 분석기법을 통해 GalT-KO 
돼지  N-글라이칸들의  정량  분석을  함으로써  야생주  돼지와의  N-
글라이코릴뉴라미닉산을 포함한 모든 N-글라이칸의  정량적 차이를 
밝혀내었다. 이 결과는 GalT-KO 이후의 이종장기이식 면역거부반응 
제 어 를  위 한  연 구 에  중 요 한  정 보 를  제 시 할  수  있 다 . 
더 나아가 돼지의 다양한 부위의 세포 및 조직들에 존재하는 당을 
데이터화한 데이터베이스 프로그램을 개발하였다. 질량 분석 기반의 
분석을 통해 얻은 당의 구조 및 정량적 정보를 바탕으로, 돼지 세포 및 
조직별 또는 질량 정보 중심의 검색을 통해 이용자들이 원하는 돼지 
당의 정보를 찾을 수 있도록 하였다. 그리고 전체적인 프로그램의 틀은 
이용자 친화적인 웹 기반의 인터페이스로 설계하였다. 그리고 돼지 조직 
표면에 발현된 당과 인간 면역세포들과의 상호작용을 탐색하기 위해서 
돼지 N-글라이칸에 대한 인간 면역세포의 활성화 측정 및 N-
글라이칸들과 결합하는 인간 수지상 면역세포 표면단백질을 규명하고자 
하였다. 
 １７９
본 연구를 통해 분석한 GalT-KO 돼지의 세포와 조직 표면에 발현된 
당의 구조 및 정량적 정보는 이종장기이식 분야에서 이종당질항원에 
대한 면역거부반응을 제어하기 위한 중요한 연구 자료가 될 수 있을 
것으로 기대한다. 
 
주요어: 이종장기이식, 면역거부반응, GalT-KO 돼지, 질량분석기법, 당, 
돼지 당 데이터베이스 
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